<!DOCTYPE html><html lang="en-GB"><head><meta charSet="utf-8"/><meta http-equiv="x-ua-compatible" content="ie=edge"/><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/><style data-href="/component---src-templates-chapter-level-2-chapter-level-2-tsx.d09ef71dfbb262c31a03.css" id="gatsby-global-css">.page-header{margin:0 0 3rem}.page-header__pre-heading{font-size:1.125rem;line-height:1.5rem;display:block;margin:0}.page-header__heading{font-size:2.75rem;line-height:3.5rem;margin:0 0 .5rem}.page-header__lead{font-size:1.25rem;line-height:1.75rem;margin:0 0 .5rem}.page-header__cta{font-size:1rem;line-height:1.5rem;display:block;margin:0}@media print{.page-header__cta{display:none!important}}.breadcrumbs{font-size:1rem;line-height:1.5rem;list-style:none;margin:.5em 0 2em;max-width:100%;padding:0}@media print{.breadcrumbs{display:none!important}}.breadcrumbs__crumb{display:inline-block}.breadcrumbs__crumb:before{content:">";font-size:80%;margin:0 .25em}.breadcrumbs__crumb:first-child:before{display:none}.breadcrumbs a{color:#222;text-decoration:underline}.breadcrumbs a:hover{text-decoration:none}.breadcrumbs a:focus{color:#005ea5}.breadcrumbs a:active{color:#222}.OldIEMessage-module--container--2Z9pT{max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);margin:auto auto 1rem}.OldIEMessage-module--alert--3CB3M{background:#ffdfa4;border:1px solid #966f2f;margin:1rem auto 0;max-width:73.125rem;padding:1rem}.OldIEMessage-module--alert--3CB3M a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.OldIEMessage-module--alert--3CB3M a:visited{color:#4c2c92}.OldIEMessage-module--alert--3CB3M a:hover{color:#2e8aca}.OldIEMessage-module--alert--3CB3M a:focus{outline:.25rem solid #0092a6;color:#005ea5}.OldIEMessage-module--alert--3CB3M a:active{color:#222}.OldIEMessage-module--alert--3CB3M h2{margin-top:0}.OldIEMessage-module--alert--3CB3M h2,.OldIEMessage-module--alert--3CB3M p{max-width:600px}.OldIEMessage-module--lastP---CQws{margin-bottom:0}.CoronaMessage-module--wrapper--zRiaV{background:#ffeb3b;padding:.5rem 0}.CoronaMessage-module--wrapper--zRiaV p{margin-top:0}.CoronaMessage-module--wrapper--zRiaV a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.CoronaMessage-module--wrapper--zRiaV a:visited{color:#4c2c92}.CoronaMessage-module--wrapper--zRiaV a:hover{color:#2e8aca}.CoronaMessage-module--wrapper--zRiaV a:focus{outline:.25rem solid #0092a6;color:#005ea5}.CoronaMessage-module--wrapper--zRiaV a:active{color:#222}@media print{.CoronaMessage-module--wrapper--zRiaV{display:none}}.CoronaMessage-module--container--36Biz{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.CoronaMessage-module--container--36Biz>:last-child{margin-bottom:0}.SubNav-module--wrapper--yAXWY{background:#fff;color:#000;display:block}.SubNav-module--list--1K9bK{margin:0;padding:0}.SubNav-module--list--1K9bK li{list-style:none;margin:0}.SubNav-module--link--39i23{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#222;display:block;font-weight:400;padding:.5rem 1rem .5rem 2rem;text-decoration:none}.SubNav-module--link--39i23:focus{color:#222;outline:.25rem solid #0092a6;outline-offset:-.5rem}.SubNav-module--link--39i23:active,.SubNav-module--link--39i23:hover,.SubNav-module--link--39i23:visited{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#222}.SubNav-module--link--39i23:hover{background:#d6d6d6;color:#222;text-decoration:underline}.SubNav-module--imageLink--3xwIS{display:none}@media(min-width:56.25em){.SubNav-module--wrapper--yAXWY{border-bottom:.125rem solid #004650;bottom:0;height:3rem;left:0;position:absolute;width:100%}.SubNav-module--imageLink--3xwIS{display:inline-block}.SubNav-module--list--1K9bK{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);height:100%}.SubNav-module--list--1K9bK li{display:inline-block;height:100%;vertical-align:middle}.SubNav-module--link--39i23{border:0;display:block;height:100%;padding:0 1rem}.SubNav-module--link--39i23[aria-current=page],.SubNav-module--link--39i23[aria-current=true]{background:transparent}.SubNav-module--link--39i23[aria-current=page]:after,.SubNav-module--link--39i23[aria-current=true]:after{display:none}.SubNav-module--link--39i23:before{content:"";display:inline-block;height:100%;vertical-align:middle}.SubNav-module--link--39i23:active,.SubNav-module--link--39i23:hover,.SubNav-module--link--39i23:visited{border:0}}.SubNav-module--image--uq-a2{height:100%}.Nav-module--link--3JzDA .Nav-module--tooltip--1Uj-W{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Nav-module--link--3JzDA:focus-visible .Nav-module--tooltip--1Uj-W{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Nav-module--visuallyHidden--ORHqX{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Nav-module--wrapper--2_xng{display:none;position:relative}@media print{.Nav-module--wrapper--2_xng{display:none!important}}@media(min-width:56.25em){.Nav-module--wrapper--2_xng{display:block}}.Nav-module--wrapperExpanded--3RxQB{display:block}.Nav-module--nav--2aQpa abbr[title]{border-bottom:0;cursor:help;text-decoration:none}.Nav-module--myAccount--3lsif{border-top:1px solid #fff}@media(min-width:56.25em){.Nav-module--myAccount--3lsif{display:none}}.Nav-module--myAccountHeading--1A5_B{border:.25rem solid #004650;font-size:100%;margin:0;padding:.5rem 1rem}.Nav-module--menuWrapper--2fp8S{background:#004650;color:#fff;padding:.25rem 0}.Nav-module--menuList--264L-{list-style:none;margin:auto;padding:0}.Nav-module--menuList--264L->li{margin:0}a.Nav-module--link--3JzDA{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#fff;display:block;font-weight:400;padding:.5rem 1rem;text-decoration:none}a.Nav-module--link--3JzDA span{text-decoration:inherit}a.Nav-module--link--3JzDA:focus{color:#fff;outline:.25rem solid #fff;outline-offset:-.5rem;z-index:1}a.Nav-module--link--3JzDA:visited{color:#fff}a.Nav-module--link--3JzDA:active{background:#acadad;color:#222}a.Nav-module--link--3JzDA:hover{background:#d6d6d6;color:#222;text-decoration:underline}a.Nav-module--link--3JzDA[aria-current=page],a.Nav-module--link--3JzDA[aria-current=true]{background:#fff;color:#222;font-weight:700}a.Nav-module--link--3JzDA[aria-current=page]:focus,a.Nav-module--link--3JzDA[aria-current=true]:focus{outline-color:#0092a6;outline-offset:-.25rem}@media(min-width:56.25em){.Nav-module--wrapperWithSubLinks--3PUfX{padding-bottom:3rem}.Nav-module--menuList--264L-{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);display:-webkit-flex;display:flex;-webkit-flex-direction:row;flex-direction:row;-webkit-flex-wrap:nowrap;flex-wrap:nowrap;-webkit-justify-content:space-between;justify-content:space-between}.Nav-module--menuList--264L->li{-webkit-flex-grow:1;flex-grow:1}a.Nav-module--link--3JzDA{border-left-width:0;border-right-width:0;display:-webkit-flex;display:flex;-webkit-flex-direction:column;flex-direction:column;height:100%;-webkit-justify-content:center;justify-content:center;line-height:1.25;margin:0;padding:.5rem;position:relative;text-align:center}a.Nav-module--link--3JzDA:focus{outline-offset:-.25rem}a.Nav-module--link--3JzDA span{display:inline-block;vertical-align:middle;white-space:normal}a.Nav-module--link--3JzDA[aria-current=page],a.Nav-module--link--3JzDA[aria-current=true]{margin:0 .25rem}a.Nav-module--link--3JzDA[aria-current=page]:focus,a.Nav-module--link--3JzDA[aria-current=true]:focus{outline-offset:-.5rem}a.Nav-module--link--3JzDA[aria-current=page]:after,a.Nav-module--link--3JzDA[aria-current=true]:after{background:#fff;content:"";display:block;height:.25rem;left:0;position:absolute;top:100%;width:100%}a.Nav-module--link--3JzDA[aria-current=page]:hover:after,a.Nav-module--link--3JzDA[aria-current=true]:hover:after{background:#d6d6d6}}@media(min-width:56.25em)and (min-width:75em){a.Nav-module--link--3JzDA{padding:1rem}}.Autocomplete-module--ac--2PqiF .autocomplete__wrapper{position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__hint,.Autocomplete-module--ac--2PqiF .autocomplete__input{-webkit-appearance:none;border:1px solid #222;border-radius:0;box-sizing:border-box;margin-bottom:0;width:100%}.Autocomplete-module--ac--2PqiF .autocomplete__input{background-color:#e9e9e9!important;height:2.5rem!important;margin:0!important;max-width:100%!important;position:relative;z-index:101}.Autocomplete-module--ac--2PqiF .autocomplete__input:focus{outline:3px solid #0092a6;outline-offset:-3px;z-index:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-webkit-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-moz-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input:-ms-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-ms-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__hint{color:#bfc1c3;position:absolute}.Autocomplete-module--ac--2PqiF .autocomplete__input--default{padding:.5rem}.Autocomplete-module--ac--2PqiF .autocomplete__input--focused{outline:3px solid #0092a6;outline-offset:-3px}.Autocomplete-module--ac--2PqiF .autocomplete__input--show-all-values{padding:4px 34px 4px 4px;cursor:pointer}.Autocomplete-module--ac--2PqiF .autocomplete__dropdown-arrow-down{z-index:-1;display:inline-block;position:absolute;right:8px;width:24px;height:24px;top:10px}.Autocomplete-module--ac--2PqiF .autocomplete__menu{background-color:#fff;border:1px solid #d6d6d6;border-top:0;color:#34384b;margin:0;max-width:100%;padding:0;text-align:left;width:-webkit-calc(100vw - 2rem);width:calc(100vw - 2rem)}@media(min-width:37.5em){.Autocomplete-module--ac--2PqiF .autocomplete__menu{width:100%}}.Autocomplete-module--ac--2PqiF .autocomplete__menu--visible{display:block}.Autocomplete-module--ac--2PqiF .autocomplete__menu--hidden{display:none}.Autocomplete-module--ac--2PqiF .autocomplete__menu--overlay{box-shadow:0 .25rem 1rem .25rem rgba(0,0,0,.1);left:0;position:absolute;top:100%;z-index:100}.Autocomplete-module--ac--2PqiF .autocomplete__menu--inline{position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__option{border-left-width:0;border-bottom:1px solid #d6d6d6;border-right-width:0;border-top-width:1px;color:#005ea5;cursor:pointer;display:block;margin:0;position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__option a{color:inherit;display:block;font-weight:400;padding:.5rem;text-decoration:none}.Autocomplete-module--ac--2PqiF .autocomplete__option mark{background:0;color:inherit;font-weight:700;padding:0}.Autocomplete-module--ac--2PqiF .autocomplete__option>*{pointer-events:none}.Autocomplete-module--ac--2PqiF .autocomplete__option:first-of-type{border-top-width:0}.Autocomplete-module--ac--2PqiF .autocomplete__option:last-of-type{border-bottom-width:0}.Autocomplete-module--ac--2PqiF .autocomplete__option--odd{background-color:#fafafa}.Autocomplete-module--ac--2PqiF .autocomplete__option--focused,.Autocomplete-module--ac--2PqiF .autocomplete__option:hover{background-color:#e9e9e9;color:#005ea5;outline:none;text-decoration:underline}.Autocomplete-module--ac--2PqiF .autocomplete__option--no-results{background-color:#fafafa;color:#646b6f;cursor:not-allowed}.Autocomplete-module--ac--2PqiF .autocomplete__hint,.Autocomplete-module--ac--2PqiF .autocomplete__input,.Autocomplete-module--ac--2PqiF .autocomplete__option{font-size:16px;line-height:1.25}.Search-module--search--2wNll{margin:0;padding-right:2.5rem;position:relative}.Search-module--label--1rrog{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute!important;width:1px}.Search-module--button--2FbnI{background:#393939;border:0;color:#fff;cursor:pointer;height:2.5rem;min-width:2.5rem;padding:0 .5rem;position:absolute;right:0;text-align:center;top:0;z-index:101}.Search-module--button--2FbnI:focus{outline:.25rem solid #0092a6}.Search-module--button--2FbnI .Search-module--icon--2JB42{font-size:150%;vertical-align:middle}.Account-module--account--1BtRh{position:relative}.Account-module--button--zZii1{background:#fff;border:1px solid #222;color:#222;cursor:pointer;display:inline-block;font-family:inherit;font-size:inherit;font-weight:400;height:2.5rem;line-height:2.5rem;padding:0 .5rem;text-decoration:none;vertical-align:middle;white-space:nowrap}.Account-module--button--zZii1:focus{outline:.25rem solid #0092a6}.Account-module--button--zZii1:visited{color:#222}.Account-module--button--zZii1:hover{border:1px solid #222}.Account-module--myAccount--3jTaq:after{border-left:.25rem solid transparent;border-right:.25rem solid transparent;border-top:.5rem solid #393939;content:"";display:inline-block;height:0;margin-left:.5rem;vertical-align:middle;width:0}.Account-module--myAccount--3jTaq[aria-expanded=true]:after{border-bottom:.5rem solid #222;border-top:0}.Account-module--menu--3C46i{background:#fff;border:1px solid #393939;list-style:none;margin:.625rem 0 0;padding:0;position:absolute;right:0;top:100%;z-index:2}.Account-module--menu--3C46i:focus{outline:.25rem solid #0092a6}.Account-module--menu--3C46i[aria-hidden=true]{display:none}.Account-module--menu--3C46i:before{border-bottom:.5rem solid #393939;border-left:.25rem solid transparent;border-right:.25rem solid transparent}.Account-module--menu--3C46i:after,.Account-module--menu--3C46i:before{bottom:100%;content:"";display:block;height:0;position:absolute;right:1rem;width:0}.Account-module--menu--3C46i:after{border-bottom:.4rem solid #fff;border-left:.2rem solid transparent;border-right:.2rem solid transparent;margin-right:1px}.Account-module--menu--3C46i li{border-top:1px solid #d6d6d6;list-style:none;margin:0}.Account-module--menu--3C46i a{color:#005ea5;display:block;padding:.5rem 1rem;text-decoration:none;white-space:nowrap}.Account-module--menu--3C46i a:focus{outline:.25rem solid #0092a6}.Account-module--menu--3C46i a:hover{background:#e9e9e9;text-decoration:underline}.Header-module--header--3os44{background:#fff;border-bottom:.125rem solid #004650;box-sizing:border-box;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif}.Header-module--header--3os44 *,.Header-module--header--3os44 :after,.Header-module--header--3os44 :before{box-sizing:inherit;font-family:inherit}@media print{.Header-module--header--3os44{border-bottom:none}}.Header-module--container--1mfIr{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);padding:1rem 0 0}.Header-module--container--1mfIr:after{clear:both;content:"";display:table}.Header-module--home--1TCPb{color:#000;display:inline-block;float:left;height:1.875rem;margin-bottom:1rem}@media print{.Header-module--home--1TCPb:after{content:none!important}}.Header-module--home--1TCPb:focus{outline:.25rem solid #0092a6}.Header-module--home--1TCPb:visited{color:#000}.Header-module--home--1TCPb .Header-module--icon--4LSt5{height:100%;width:auto}.Header-module--wrapper--2e13D{display:-webkit-flex;display:flex;-webkit-flex-grow:1;flex-grow:1;float:right;-webkit-justify-content:space-between;justify-content:space-between;margin-bottom:1rem;width:50%}@media print{.Header-module--wrapper--2e13D{display:none!important}}.Header-module--wrapper--2e13D:after{clear:both;content:"";display:table}.Header-module--search--2nfnz{-webkit-flex-grow:1;flex-grow:1;float:left;margin-right:1rem;min-width:66.6666666667%}.Header-module--mobileMenuBtn--1LgyL{-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:1px solid #222;float:right;font-family:inherit;font-size:110%;height:2.5rem;min-width:4.6875rem;white-space:nowrap}.Header-module--mobileMenuBtn--1LgyL:after{border-left:.25rem solid transparent;border-right:.25rem solid transparent;border-top:.5rem solid #393939;content:"";display:inline-block;height:0;margin-left:.5rem;vertical-align:middle;width:0}.Header-module--mobileMenuBtn--1LgyL[aria-expanded=true]:after{border-bottom:.5rem solid #222;border-top:0}.Header-module--account--y72Q4{display:none}@media(max-width:56.24em){.Header-module--home--1TCPb{float:none}.Header-module--wrapper--2e13D{float:none;width:auto}}@media(min-width:56.25em){.Header-module--header--3os44{border-bottom:.25rem solid #fff}.Header-module--container--1mfIr{display:-webkit-flex;display:flex;-webkit-justify-content:space-between;justify-content:space-between}.Header-module--home--1TCPb{height:2.5rem;margin-right:2rem}.Header-module--wrapper--2e13D{-webkit-justify-content:flex-end;justify-content:flex-end}.Header-module--search--2nfnz{margin-right:2rem}.Header-module--mobileMenuBtn--1LgyL{display:none}.Header-module--account--y72Q4{display:block}}.SkipLinks-module--list--1WwLa{list-style:none;margin:0;padding:0}@media print{.SkipLinks-module--list--1WwLa{display:none!important}}.SkipLinks-module--list--1WwLa li{list-style:none;margin:0}.SkipLinks-module--link--hkZw8{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.SkipLinks-module--link--hkZw8:focus{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;left:.25rem;outline:3px solid #0092a6;overflow:visible;padding:.5rem 1rem;position:absolute;top:.25rem;white-space:nowrap;width:auto;z-index:1}.Social-module--wrapper--2nKsd{clear:left}.Social-module--list--E5R5J{list-style:none;margin:0;max-width:100%;padding:0}.Social-module--list--E5R5J li{margin:0 0 .25rem}.Social-module--list--E5R5J svg{margin:-.125rem .25rem 0 0;vertical-align:middle}@media(min-width:37.5em){.Social-module--list--E5R5J li{float:left;margin:0 1rem 0 0}}@media(min-width:56.25em){.Social-module--wrapper--2nKsd{clear:none}.Social-module--wrapper--2nKsd li{float:none;margin:0 0 .25rem}}.Legal-module--wrapper--3AYMO{font-size:.875rem;line-height:1.25rem;background:#393939;padding:1rem 0}.Legal-module--wrapper--3AYMO a{text-decoration:underline}.Legal-module--container--3TTBh{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.Legal-module--menu--1e1Iy{margin:0 0 1rem}@media print{.Legal-module--menu--1e1Iy{display:none!important}}.Legal-module--menu--1e1Iy ul{list-style:none;margin:0;max-width:100%;padding:0}.Legal-module--menu--1e1Iy li{margin:0}.Legal-module--menu--1e1Iy a{display:block}.Legal-module--copyright--34nsI{font-size:.875rem;line-height:1.25rem;margin:0}@media print{.Legal-module--copyright--34nsI{float:none!important;max-width:100%}}@media(min-width:37.5em){.Legal-module--menu--1e1Iy li{display:inline-block;margin-right:1rem}}@media(min-width:75em){.Legal-module--wrapper--3AYMO:after,.Legal-module--wrapper--3AYMO:before{content:" ";display:table}.Legal-module--wrapper--3AYMO:after{clear:both}.Legal-module--menu--1e1Iy{float:left;margin:0}.Legal-module--copyright--34nsI{float:right}}.Services-module--link--2y_1q .Services-module--tooltip--pg3nW{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Services-module--link--2y_1q:focus-visible .Services-module--tooltip--pg3nW{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Services-module--visuallyHidden--t9mfm{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Services-module--wrapper--2qOoE{margin:0 0 2rem}.Services-module--list--3SZQu{list-style:none;margin:0;padding:0}.Services-module--list--3SZQu li{margin:0 0 .25rem}@media(min-width:37.5em){.Services-module--wrapper--2qOoE{border-right:2px solid #393939;float:left;width:33.3333333333%}}@media(min-width:56.25em){.Services-module--wrapper--2qOoE{border-right:2px solid #393939;float:left;margin:0;width:25%}}.Pages-module--wrapper--30REl{margin:0 0 2rem}.Pages-module--list--vvSk4{list-style:none;margin:0;padding:0}.Pages-module--list--vvSk4 li{margin:0 0 .25rem}@media(min-width:25em){.Pages-module--list--vvSk4{-webkit-column-count:2;-moz-column-count:2;column-count:2;-webkit-column-gap:1rem;-moz-column-gap:1rem;column-gap:1rem}}@media(min-width:37.5em){.Pages-module--wrapper--30REl{float:left;margin:0;padding:0 0 0 2rem;width:66.6666666667%}}@media(min-width:56.25em){.Pages-module--wrapper--30REl{float:left;margin:0;padding:0 2rem;width:50%}.Pages-module--list--vvSk4{-webkit-column-count:2;-moz-column-count:2;column-count:2;-webkit-column-gap:1rem;-moz-column-gap:1rem;column-gap:1rem}}.Footer-module--link--CGIYk .Footer-module--tooltip--1zoJv{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Footer-module--link--CGIYk:focus-visible .Footer-module--tooltip--1zoJv{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Footer-module--visuallyHidden--3CCnP{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Footer-module--footer--2QrGZ{background:#222;box-sizing:border-box;color:#fff;contain-intrinsic-size:350px;content-visibility:auto;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif;margin:2rem 0 0}.Footer-module--footer--2QrGZ a{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.Footer-module--footer--2QrGZ a:visited{color:#fff}.Footer-module--footer--2QrGZ a:hover{color:#d6d6d6}.Footer-module--footer--2QrGZ a:focus{outline:.25rem solid #fff;color:#fff}.Footer-module--footer--2QrGZ a:active{color:#d6d6d6}.Footer-module--footer--2QrGZ *,.Footer-module--footer--2QrGZ :after,.Footer-module--footer--2QrGZ :before{box-sizing:inherit}.Footer-module--footer--2QrGZ a{font-weight:400}.Footer-module--container--1iuoB{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);padding:1rem 0}.Footer-module--container--1iuoB:after,.Footer-module--container--1iuoB:before{content:" ";display:table}.Footer-module--container--1iuoB:after{clear:both}@media print{.Footer-module--container--1iuoB{display:none!important}}.Footer-module--logo--3DGKv{display:block;height:0;margin:0 0 2rem;padding:0 0 29.0496453901px;position:relative;width:80px}.Footer-module--logo--3DGKv svg{display:block;height:100%!important;left:0;position:absolute;top:0;width:100%!important}@media(min-width:56.25em){.Footer-module--logo--3DGKv{margin-bottom:1rem}}.BackToTop-module--wrapper--2Z0EU{margin-top:3rem}@media print{.BackToTop-module--wrapper--2Z0EU{display:none}}.BackToTop-module--nav--1DPZ6{background:#e9e9e9;border-top:1px solid #adadad;width:100%;z-index:1}.BackToTop-module--anchor--1Nia6{display:block;line-height:1rem;padding:1rem 0}.BackToTop-module--anchor--1Nia6:visited{color:#005ea5}.BackToTop-module--anchor--1Nia6 svg{-webkit-transition:all .25s ease;transition:all .25s ease}.BackToTop-module--anchor--1Nia6:hover{background:#f4f4f4}.BackToTop-module--anchor--1Nia6:hover svg{-webkit-transform:translateY(-.125rem);transform:translateY(-.125rem)}@supports((position:-webkit-sticky) or (position:sticky)){.BackToTop-module--wrapper--2Z0EU{bottom:0;left:0;margin:0;pointer-events:none;position:absolute;right:0;top:min(100vh,-webkit-calc(100% - 3rem));top:min(100vh,calc(100% - 3rem));width:100%;z-index:99}.BackToTop-module--nav--1DPZ6{position:-webkit-sticky;position:sticky;pointer-events:all;top:-webkit-calc(100vh - 3rem);top:calc(100vh - 3rem);background:#e9e9e9;border-top:1px solid #adadad;width:100%;z-index:1}}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:400;src:local("Lato"),url(../../../../fonts/lato-v17-latin-regular.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-regular.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:italic;font-weight:400;src:local("Lato"),url(../../../../fonts/lato-v17-latin-italic.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-italic.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:700;src:local("Lato"),url(../../../../fonts/lato-v17-latin-700.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-700.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:900;src:local("Lato"),url(../../../../fonts/lato-v17-latin-900.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-900.woff) format("woff")}/*! normalize.css v8.0.1 | MIT License | github.com/necolas/normalize.css */html{line-height:1.15;-webkit-text-size-adjust:100%}body{margin:0}main{display:block}h1{font-size:2em;margin:.67em 0}hr{box-sizing:content-box;height:0;overflow:visible}pre{font-family:monospace,monospace;font-size:1em}a{background-color:transparent}abbr[title]{border-bottom:none;text-decoration:underline;-webkit-text-decoration:underline dotted;text-decoration:underline dotted}b,strong{font-weight:bolder}code,kbd,samp{font-family:monospace,monospace;font-size:1em}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sub{bottom:-.25em}sup{top:-.5em}img{border-style:none}button,input,optgroup,select,textarea{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=button],[type=reset],[type=submit],button{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}fieldset{padding:.35em .75em .625em}legend{box-sizing:border-box;color:inherit;display:table;max-width:100%;padding:0;white-space:normal}progress{vertical-align:baseline}textarea{overflow:auto}[type=checkbox],[type=radio]{box-sizing:border-box;padding:0}[type=number]::-webkit-inner-spin-button,[type=number]::-webkit-outer-spin-button{height:auto}[type=search]{-webkit-appearance:textfield;outline-offset:-2px}[type=search]::-webkit-search-decoration{-webkit-appearance:none}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}details{display:block}summary{display:list-item}[hidden],template{display:none}.show-print{display:none!important}@media print{.show-print{display:block!important}}@media print{.hide-print{display:none!important}}@media print{.remove-appended-print-link:after{content:none!important}}@media print{*{background:transparent!important;box-shadow:none!important;color:#000!important;text-shadow:none!important}a,a:visited{text-decoration:underline}}@media print{h1 a:after,h2 a:after,h3 a:after,h4 a:after,h5 a:after,h6 a:after{content:none!important}}@media print{a[href]:after{content:" (" attr(href) ")"}}@media print{abbr[title]:after{content:" (" attr(title) ")"}}@media print{.ir a:after,a[href^="#"]:after,a[href^="javascript:"]:after{content:""}}@media print{blockquote,pre{border:1px solid #999;page-break-inside:avoid}}@media print{thead{display:table-header-group}}@media print{img,tr{page-break-inside:avoid}}@media print{img{max-width:100%!important}}@media print{img:not([alt]),img[alt=""]{display:none!important}}@media print{@page{margin:.5cm}}@media print{h2,h3,p{orphans:3;widows:3}}@media print{h2,h3{page-break-after:avoid}}.clearfix:after,.clearfix:before{content:" ";display:table}.clearfix:after{clear:both}.container{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.container--full{max-width:100%;padding:0 2%;width:auto}html{box-sizing:border-box;font-size:.9375rem;overflow-x:hidden}html *,html :after,html :before{box-sizing:inherit}@media(min-width:56.25em){html{font-size:1.03125rem;font-size:-webkit-calc(.375rem + 1vw);font-size:calc(.375rem + 1vw)}}@media(min-width:75em){html{font-size:1.125rem}}body{background:#f4f4f4;color:#222;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif;font-style:normal;line-height:1.5rem;overflow-x:hidden;text-rendering:optimizelegibility}img{max-width:100%}hr{background:0;border:0;border-top:.0625em solid #adadad;margin:2em 0;padding:0}.p,p{font-size:1rem;line-height:1.5rem;font-feature-settings:"kern","onum","liga"}.lead,.p,p{margin-bottom:1rem;margin-top:1rem;font-weight:400;max-width:66ch}.lead{font-size:1.25rem;line-height:1.75rem}code{background:#e9e9e9;border:1px solid #adadad;border-radius:.125em;color:#222;display:inline-block;font-family:Monaco,Menlo,Consolas,Courier New,monospace;margin:0 0 .125em;padding:0 .25em}pre code{background:transparent;border:0;margin:0}.mark,mark{background-color:#fff999;padding:0 .25em}.small,small{font-size:85%}.h6,h6{font-size:1rem}.h5,.h6,h5,h6{line-height:1.5rem;margin-bottom:1rem;margin-top:1rem;clear:both;font-weight:700;max-width:66ch}.h5,h5{font-size:1.125rem}.h4,h4{font-size:1.25rem;line-height:1.75rem;margin-bottom:1rem;margin-top:1rem;clear:both;font-weight:700;max-width:66ch}.h3,h3{font-size:1.75rem;line-height:2rem}.h2,.h3,h2,h3{margin-bottom:1rem;margin-top:2rem;clear:both;font-weight:700;max-width:66ch}.h2,h2{font-size:2.25rem;line-height:2.5rem}.h1,.h2+.h3,.h2+h3,h1,h2+.h3,h2+h3{margin-top:0}.h1,h1{font-size:2.75rem;line-height:3.5rem;margin-bottom:1rem;clear:both;font-weight:900;max-width:66ch}.h1+.h2,.h1+h2,h1+.h2,h1+h2{margin-top:0}a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}a:visited{color:#4c2c92}a:hover{color:#2e8aca}a:focus{outline:.25rem solid #0092a6;color:#005ea5}a:active{color:#222}.link--inverse{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.link--inverse:visited{color:#fff}.link--inverse:hover{color:#d6d6d6}.link--inverse:focus{outline:.25rem solid #fff;color:#fff}.link--inverse:active{color:#d6d6d6}.inverse-links a{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.inverse-links a:visited{color:#fff}.inverse-links a:hover{color:#d6d6d6}.inverse-links a:focus{outline:.25rem solid #fff;color:#fff}.inverse-links a:active{color:#d6d6d6}.list,ol,ul{font-feature-settings:"kern","onum","liga";margin-left:1rem;max-width:66ch;padding:0}.list--unstyled{list-style:none;margin-left:0;max-width:none;padding:0}.list--loose .list__item,.list--loose li{margin-bottom:.25rem}.list--piped{list-style:none;margin-left:0;padding:0}.list--piped .list__item,.list--piped li{display:inline-block;margin-right:-.25rem}.list--piped .list__item a,.list--piped li a{padding:.5rem}.list--piped .list__item:after,.list--piped li:after{border-left:1px solid #004650;content:"\200B";display:inline-block;margin:0 .5em;overflow:hidden;text-indent:-99px;vertical-align:middle;width:0}.list--piped .list__item:first-child a,.list--piped li:first-child a{padding-left:0}.list--piped .list__item:last-child:after,.list--piped li:last-child:after{display:none}.quote{font-size:1.25rem;line-height:1.75rem;border-left:.25em solid #004650;font-weight:400;margin:2rem 0;padding:0 0 0 4rem;position:relative}.quote:before{color:#004650;content:"\201C";display:block;font-family:Arial,sans-serif;font-size:5rem;font-weight:700;left:0;line-height:.8;position:absolute;text-align:center;top:0;width:4rem}@media print{.quote:before{color:#000}}.quote p{font-size:inherit}.quote cite,.quote footer{font-size:1rem;line-height:1.5rem;font-style:normal}table{background:#fff;border:1px solid #adadad;border-collapse:collapse;display:block;margin:0 0 1rem;max-width:100%;overflow-y:hidden;overflow-x:auto;width:100%!important}table th{vertical-align:bottom}table td{vertical-align:top}table td,table th{border:1px solid #adadad;padding:.5rem;text-align:left}table td:first-child,table th:first-child{border-left:0}table td:last-child,table th:last-child{border-right:0}table td p,table th p{margin-top:0}table :not(thead)+tbody tr:first-child th,table tbody tr:first-child th,table thead tr:first-child th{border-top:0}table tbody tr:last-child td{border-bottom:0}table tbody tr:nth-child(2n)>td{background-color:#e9e9e9}html{overflow-x:visible;scroll-behavior:smooth}@media(prefers-reduced-motion){html{scroll-behavior:auto}}body{font-family:Lato,Trebuchet MS,Roboto,Helvetica Neue,Helvetica,Arial,sans-serif;position:relative}.visually-hidden{position:absolute;overflow:hidden;clip:rect(0 0 0 0);height:1px;width:1px;margin:-1px;padding:0;border:0}#content-start:focus{outline:none}footer{margin-top:0!important}@supports((position:-webkit-sticky) or (position:sticky)){.Layout-module--main--1OIFf{position:relative;padding-bottom:4rem}}.stacked-nav{background:#fff;border:1px solid #adadad;margin:0 0 2em}@media print{.stacked-nav{display:none!important}}.stacked-nav__root{font-size:1rem;line-height:1.5rem;border-bottom:1px solid #adadad;font-weight:700;margin:0;max-width:none;position:relative;text-decoration:none}.stacked-nav__root a{color:#222}.stacked-nav__root--no-link{padding:.5em}.stacked-nav__hint{color:#222;display:block}.stacked-nav__hint :active{color:#fff}.stacked-nav__list{list-style:none;margin:0;max-width:100%;padding:0}.stacked-nav__list-item{border-top:1px solid #adadad}.stacked-nav__content-wrapper{display:block}.stacked-nav a{color:#005ea5;display:block;padding:.5em;position:relative;text-decoration:none}.stacked-nav a[aria-current=page],.stacked-nav a[aria-current=true]{background:#e9e9e9;font-weight:700}.stacked-nav a[aria-current=page]:before,.stacked-nav a[aria-current=true]:before{background:#004650;content:"";display:block;height:100%;left:0;position:absolute;top:0;width:.25em}.stacked-nav a:hover{background:#d6d6d6}.stacked-nav a:active{background:#004650;color:#fff}.stacked-nav a:active span{color:#fff}.stacked-nav__nested{list-style:none;margin:0;padding:0}.stacked-nav__nested .stacked-nav__content-wrapper{padding-left:1rem!important}.stacked-nav__nested ul .stacked-nav__content-wrapper{padding-left:2rem!important}.TopicChaptersMenu-module--toggleButton--2MGXA{-webkit-appearance:none;-moz-appearance:none;appearance:none;background:#e9e9e9;border:1px solid #adadad;color:#005ea5;cursor:pointer;display:block;margin:0 0 2rem;padding:1rem 2rem 1rem .5rem;position:relative;text-align:left;width:100%}.TopicChaptersMenu-module--toggleButton--2MGXA:focus{outline:.25rem solid #0092a6;z-index:1}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=false]+.stacked-nav{display:none}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=true]{border-bottom:0;margin:0}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=true]+.stacked-nav{display:block}@media(min-width:37.5em){.TopicChaptersMenu-module--toggleButton--2MGXA{display:none}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded]+.stacked-nav{display:block}}.TopicChaptersMenu-module--icon--27uSj{color:#005ea5;right:.5rem;position:absolute;top:50%;-webkit-transform:translateY(-50%);transform:translateY(-50%)}.ChapterContents-module--wrapper--3ONbu{position:relative}.ChapterContents-module--printBtn--Rk_Zs{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto;-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:0;bottom:100%;cursor:pointer;display:none;padding:0}.ChapterContents-module--printBtn--Rk_Zs:visited{color:#4c2c92}.ChapterContents-module--printBtn--Rk_Zs:hover{color:#2e8aca}.ChapterContents-module--printBtn--Rk_Zs:focus{outline:.25rem solid #0092a6;color:#005ea5}.ChapterContents-module--printBtn--Rk_Zs:active{color:#222}.ChapterContents-module--printBtn--Rk_Zs svg{font-size:1.25rem;line-height:1.75rem;color:#0e0e0e;margin-right:.5rem;vertical-align:text-bottom}.ChapterContents-module--printBtn--Rk_Zs:hover svg{color:#2e8aca}@media(min-width:37.5em){.ChapterContents-module--wrapper--3ONbu:after,.ChapterContents-module--wrapper--3ONbu:before{content:" ";display:table}.ChapterContents-module--wrapper--3ONbu:after{clear:both}.ChapterContents-module--menu--3Epka{float:left;margin-right:1rem;width:-webkit-calc(25% - .5rem);width:calc(25% - .5rem)}.ChapterContents-module--landing--3klSq,.ChapterContents-module--onThisPage--1333P{float:right;width:-webkit-calc(75% - .5rem);width:calc(75% - .5rem)}.ChapterContents-module--body--1XBoo{margin-left:calc(25% + .5rem);overflow:hidden;width:-webkit-calc(75% - .5rem);width:calc(75% - .5rem)}}@media(min-width:56.25em){.ChapterContents-module--printBtn--Rk_Zs{display:block;margin-bottom:3rem;position:absolute;right:0}.ChapterContents-module--menu--3Epka{margin-right:2rem;width:-webkit-calc(25% - 1rem);width:calc(25% - 1rem)}.ChapterContents-module--landing--3klSq{width:-webkit-calc(75% - 1rem);width:calc(75% - 1rem)}.ChapterContents-module--onThisPage--1333P{position:-webkit-sticky;position:sticky;top:0;width:-webkit-calc(16.66667% - 1rem);width:calc(16.66667% - 1rem)}.ChapterContents-module--body--1XBoo{margin-left:calc(25% + 1rem);width:-webkit-calc(58.33333% - 2rem);width:calc(58.33333% - 2rem)}}@media print{.ChapterContents-module--menu--3Epka,.ChapterContents-module--onThisPage--1333P,.ChapterContents-module--printBtn--Rk_Zs{display:none}.ChapterContents-module--body--1XBoo{width:100%}}.ChapterBody-module--wrapper--2HCfk>.visually-hidden:first-child+*>:first-child{margin-top:0}.ChapterBody-module--wrapper--2HCfk h2:focus,.ChapterBody-module--wrapper--2HCfk h3:focus,.ChapterBody-module--wrapper--2HCfk h4:focus,.ChapterBody-module--wrapper--2HCfk h5:focus,.ChapterBody-module--wrapper--2HCfk h6:focus{outline:0!important}.ChapterBody-module--basisWrapper--3JBM_{border:1px solid #adadad;margin-top:1rem;max-width:66ch}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--headerWrapper--qSIFw>:first-child{margin-top:0}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK{padding:0 1rem 1rem}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK>:last-child{margin-bottom:0}.ChapterBody-module--headerWrapper--qSIFw{padding:1rem;position:relative}.ChapterBody-module--toggleBtn--3g0p7{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto;-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:0;cursor:pointer;display:block;margin-top:-.5rem;padding:0}.ChapterBody-module--toggleBtn--3g0p7:visited{color:#4c2c92}.ChapterBody-module--toggleBtn--3g0p7:hover{color:#2e8aca}.ChapterBody-module--toggleBtn--3g0p7:focus{outline:.25rem solid #0092a6;color:#005ea5}.ChapterBody-module--toggleBtn--3g0p7:active{color:#222}.ChapterBody-module--toggleBtn--3g0p7:after{content:"";height:100%;left:0;position:absolute;top:0;width:100%}.ChapterBody-module--toggleBtn--3g0p7 svg{font-size:1.125rem;line-height:1.5rem;color:#0e0e0e;margin-right:.5rem;vertical-align:text-bottom}.ChapterBody-module--toggleBtn--3g0p7:hover svg{color:#2e8aca}.ChapterBody-module--body--2n0CK[aria-hidden=true]{display:none}@media print{.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--headerWrapper--qSIFw>:first-child{margin-bottom:0}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK[aria-hidden=true]{display:block}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--toggleBtn--3g0p7{display:none}}.ChapterOnThisPage-module--wrapper--2zc7n{margin-bottom:2rem}.ChapterOnThisPage-module--heading--2SdDN{margin-top:0}.ChapterOnThisPage-module--rootList--2II70{list-style:disc}.ChapterOnThisPage-module--subList--Pwxy9{list-style:circle}.ChapterOnThisPage-module--basisForRecs--1xLSs{display:none}@media(min-width:56.25em){.ChapterOnThisPage-module--heading--2SdDN{font-size:1.25rem;line-height:1.75rem;margin-bottom:1rem;margin-top:0}@supports((position:-webkit-sticky) or (position:sticky)){.ChapterOnThisPage-module--rootList--2II70 a[aria-current=location]{font-weight:700}.ChapterOnThisPage-module--rootList--2II70 a:focus+.ChapterOnThisPage-module--subList--Pwxy9{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--subList--Pwxy9{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.ChapterOnThisPage-module--subList--Pwxy9:focus-within{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--expandedSubList--1m1WN{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--basisForRecs--1xLSs{display:list-item}}}</style><link rel="sitemap" type="application/xml" href="../../../../sitemap.xml"/><title data-react-helmet="true">Scenario: Management of vitamin D deficiency or insufficiency | Management | Vitamin D deficiency in children | CKS | NICE</title><link data-react-helmet="true" rel="search" type="application/opensearchdescription+xml" href="../../../../opensearch.xml" title="CKS"/><link data-react-helmet="true" rel="icon" href="../../../../favicon.ico"/><link data-react-helmet="true" rel="canonical" href="index.html"/><meta data-react-helmet="true" name="description" content="Covers the management of children and young people with confirmed vitamin D deficiency or insufficiency."/><meta data-react-helmet="true" property="og:description" content="Covers the management of children and young people with confirmed vitamin D deficiency or insufficiency."/><meta data-react-helmet="true" property="og:url" content="https://cks.nice.org.uk/topics/vitamin-d-deficiency-in-children/management/management-of-vitamin-d-deficiency-or-insufficiency/"/><meta data-react-helmet="true" property="og:locale" content="en_GB"/><meta data-react-helmet="true" property="og:type" content="website"/><meta data-react-helmet="true" property="og:title" content="Scenario: Management of vitamin D deficiency or insufficiency | Management | Vitamin D deficiency in children | CKS | NICE"/><meta data-react-helmet="true" property="og:image" content="https://cks.nice.org.uk/open-graph-image.png"/><meta data-react-helmet="true" property="og:image:width" content="1200"/><meta data-react-helmet="true" property="og:image:height" content="630"/><meta data-react-helmet="true" name="twitter:card" content="summary"/><meta data-react-helmet="true" name="twitter:image" content="https://cks.nice.org.uk/twitter-summary-image.png"/><meta data-react-helmet="true" name="twitter:image:alt" content="NICE and CKS logos"/><meta data-react-helmet="true" name="twitter:site" content="@NICEcomms"/><meta data-react-helmet="true" name="twitter:creator" content="@NICEcomms"/><meta data-react-helmet="true" name="theme-color" content="#004650"/><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+'';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer', 'GTM-54QC4NL');</script><link rel="manifest" href="../../../../manifest.webmanifest" crossorigin="anonymous"/><meta name="theme-color" content="#004650"/><link rel="apple-touch-icon" sizes="48x48" href="../../../../icons/icon-48x48.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="72x72" href="../../../../icons/icon-72x72.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="96x96" href="../../../../icons/icon-96x96.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="144x144" href="../../../../icons/icon-144x144.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="192x192" href="../../../../icons/icon-192x192.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="256x256" href="../../../../icons/icon-256x256.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="384x384" href="../../../../icons/icon-384x384.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="512x512" href="../../../../icons/icon-512x512.png@v=28734348209eeeae5c03a37867f1beb1"/><link as="script" rel="preload" href="../../../../webpack-runtime-28c424ef71f39faedaf0.js"/><link as="script" rel="preload" href="../../../../framework-34da02e39e1f104d9937.js"/><link as="script" rel="preload" href="../../../../app-53a71c38b210970893c4.js"/><link as="script" rel="preload" href="../../../../b95b9d9ffa67e6928854e772968693a58a7317d7-a9e1e5c953d4eee49b87.js"/><link as="script" rel="preload" href="../../../../0ad1f03a47300760909b2ab244b34289611800a7-fa70b32ffeeba2673019.js"/><link as="script" rel="preload" href="../../../../component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js"/><link as="fetch" rel="preload" href="../../../../page-data/topics/vitamin-d-deficiency-in-children/management/management-of-vitamin-d-deficiency-or-insufficiency/page-data.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="../../../../page-data/sq/d/3666801979.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="../../../../page-data/app-data.json" crossorigin="anonymous"/><script src="https://cdn.nice.org.uk/cookie-banner/cookie-banner.min.js" type="text/javascript" async=""></script></head><body><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54QC4NL" height="0" width="0" style="display: none; visibility: hidden" aria-hidden="true"></iframe></noscript><div id="___gatsby"><div style="outline:none" tabindex="-1" id="gatsby-focus-wrapper"><div><div class="Header-module--header--3os44"><header aria-label="Site header"><ul class="SkipLinks-module--list--1WwLa" aria-label="Accessibility links"><li><a href="index.html#content-start" class="SkipLinks-module--link--hkZw8">Skip to content</a></li><li><a href="https://www.nice.org.uk/accessibility" class="SkipLinks-module--link--hkZw8">Accessibility help</a></li></ul><div class="Header-module--container--1mfIr"><a href="https://www.nice.org.uk/" aria-label="Home" class="Header-module--home--1TCPb"><svg viewBox="0 0 4616 512" fill="none" class="Header-module--icon--4LSt5" aria-hidden="true" focusable="false"><path d="M1626 44v175h-22L1497 71v148h-19V44h22l107 147V44h19zm130 154a52 52 0 01-47 23c-18 0-34-7-45-20a70 70 0 01-18-48c0-19 6-35 18-48 11-14 27-20 47-20 19 0 34 8 45 23V87h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-34 15c-8 9-12 21-12 35s4 26 12 35c9 10 20 15 34 15zm109 16V104h-27V87h27V40h19v47h30v17h-30v115h-19zm88-180v26h-21V39h21zm-20 48h20v132h-20V87zm107-2c20 0 35 6 48 20 11 12 17 28 17 48 0 19-6 36-17 48a61 61 0 01-48 20c-19 0-35-7-47-20a69 69 0 01-17-48c0-20 5-36 17-48 12-14 28-20 47-20zm0 118c14 0 25-5 34-15 7-9 11-21 11-35s-4-26-11-35c-9-10-20-15-34-15s-25 5-33 15c-8 9-12 21-12 35s4 26 12 35c8 10 19 15 33 15zm107-116v21c5-7 11-12 18-17 6-4 14-6 23-6 8 0 16 1 22 4 6 2 12 6 17 11 10 10 16 24 16 42v77h-20v-76c0-13-3-22-10-29-7-8-16-11-26-11a38 38 0 00-40 40v76h-19V87h19zm222 111a52 52 0 01-46 23c-19 0-34-7-46-20a71 71 0 01-17-48c0-19 5-35 17-48 12-14 27-20 47-20 19 0 35 8 45 23V87h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-34 15c-8 9-12 21-12 35s4 26 12 35c9 10 20 15 34 15zm114 16h-19V34h19v185zm108 0h-19V44h19v175zm55-132v21c5-7 10-12 17-17 7-4 15-6 23-6 9 0 17 1 23 4 6 2 12 6 16 11 11 10 16 24 16 42v77h-19v-76c0-13-4-22-10-29-7-8-16-11-27-11a38 38 0 00-39 40v76h-19V87h19zm202 35c-2-13-13-20-33-20s-30 6-30 19c0 5 2 9 6 12 5 2 10 5 16 6l21 5 21 7c7 2 12 6 16 11 5 5 7 11 7 19 0 13-5 23-15 30-9 7-22 10-38 10-18 0-32-4-42-13-9-8-14-18-15-31h20c2 13 8 21 21 25l13 2 13-1 11-3c8-3 12-9 12-17 0-5-2-9-6-12s-10-6-16-7l-21-5-21-7c-7-2-12-6-16-10-4-5-6-11-6-19 0-12 4-22 12-28 9-7 22-10 39-10 15 0 28 4 37 11 8 7 12 16 14 26h-20zm60 97V104h-26V87h26V40h20v47h30v17h-30v115h-20zm89-180v26h-21V39h21zm-21 48h20v132h-20V87zm65 132V104h-26V87h26V40h20v47h30v17h-30v115h-20zm162 0v-21c-4 7-10 12-17 16-7 5-14 7-23 7s-16-1-22-4c-7-2-12-6-17-11a57 57 0 01-16-42V87h20v76c0 12 3 22 10 29 6 7 15 11 26 11a39 39 0 0039-40V87h20v132h-20zm65 0V104h-26V87h26V40h20v47h30v17h-30v115h-20zm124-16c17 0 30-7 37-22h22c-5 12-12 22-22 29-9 7-22 11-38 11-19 0-35-7-47-20a68 68 0 01-18-48c0-20 5-36 17-48 12-14 28-20 47-20 20 0 35 6 48 20 11 12 17 28 17 48v8h-109c1 12 6 22 14 30s19 12 32 12zm-2-100c-12 0-22 4-30 11s-12 17-14 28h88c-1-11-6-21-14-28s-18-11-30-11zm195-52c-9 0-16 2-21 6-4 4-7 11-7 20v10h30v17h-30v115h-19V104h-23V87h23V75c0-14 4-25 12-32 9-7 21-11 36-11h1v19h-2zm75 34c19 0 35 6 47 20 12 12 18 28 18 48 0 19-6 36-18 48a61 61 0 01-47 20c-19 0-35-7-47-20a69 69 0 01-18-48c0-20 6-36 18-48 12-14 28-20 47-20zm0 118c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-33 15c-8 9-12 21-12 35s4 26 12 35c8 10 19 15 33 15zm156-118v20h-2c-14 0-25 5-34 17-9 11-13 24-13 39v58h-19V87h19v32c4-13 13-23 27-30 6-3 13-4 21-4h1zM1617 293v175h-19v-78h-101v78h-19V293h19v78h101v-78h19zm91 159c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19 11 13 17 29 17 49v8h-109c1 12 6 22 14 30 9 8 19 12 32 12zm-1-100c-12 0-22 3-31 11-7 7-12 17-14 28h89c-2-11-7-21-14-28-8-8-18-11-30-11zm187 95a52 52 0 01-47 23c-18 0-34-7-45-20a70 70 0 01-18-48c0-19 6-36 18-49 11-13 27-19 47-19 19 0 34 7 45 23v-21h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm114 16h-19V283h19v185zm46 0V353h-27v-17h27v-48h19v48h30v17h-30v115h-19zm87-185v73l17-16c7-4 15-6 24-6 8 0 16 1 22 3a58 58 0 0133 54v77h-20v-77c0-12-3-21-10-29-7-7-16-10-26-10a39 39 0 00-40 40v76h-19V283h19zm280 164a52 52 0 01-47 23c-19 0-34-7-46-20a70 70 0 01-17-48c0-19 6-36 17-49 12-13 28-19 47-19 20 0 35 7 46 23v-21h19v132h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm109-116v20c5-6 10-11 17-16 7-4 15-6 23-6 9 0 17 1 23 3 6 3 11 6 16 11 11 11 16 25 16 43v77h-19v-77c0-12-4-21-10-29-7-7-16-10-27-10a39 39 0 00-39 40v76h-19V336h19zm222 111a52 52 0 01-47 23c-19 0-34-7-46-20a71 71 0 01-17-48c0-19 6-36 17-49 12-13 28-19 47-19 20 0 35 7 46 23v-74h19v185h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm233-1a56 56 0 0053-36h21c-6 17-15 30-28 39a82 82 0 01-50 16c-25 0-46-9-61-26a92 92 0 01-22-64c0-25 7-46 22-63 15-18 36-26 61-26a78 78 0 0178 54h-21c-4-11-11-19-20-25-10-7-20-10-33-10-12 0-22 2-30 5-9 4-15 9-21 15a73 73 0 00-17 50c0 21 6 37 17 50 12 14 29 21 51 21zm198-4a52 52 0 01-47 23c-19 0-34-7-46-20a70 70 0 01-17-48c0-19 6-36 17-49 12-13 28-19 48-19 19 0 34 7 45 23v-21h19v132h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm163-118v19h-2c-14 0-26 6-34 18-9 10-13 23-13 39v58h-19V336h19v32c4-14 13-24 27-30 6-3 13-4 21-4h1zm73 118c18 0 31-8 38-22h21c-4 12-11 21-21 29-10 7-22 11-38 11-19 0-35-7-48-20a68 68 0 01-18-48c0-20 6-36 18-49s27-19 47-19c19 0 35 6 47 19s17 29 17 49v8h-109c2 12 7 22 15 30s19 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-14 28h88c-2-11-6-21-14-28-8-8-18-11-30-11zm162-40v59h96v19h-96v59h108v19h-127V293h127v19h-108zm189 88l51 68h-25l-37-54-37 54h-25l51-68-48-64h25l34 50 33-50h25l-47 64zm120 52c9 0 16-3 23-7 6-5 11-11 14-19h21c-4 13-12 24-22 32-11 8-24 12-40 12-19 0-34-7-46-20a69 69 0 01-18-48c0-20 6-36 18-49s27-19 46-19a60 60 0 0161 44h-20c-3-8-8-15-14-19-7-5-14-7-23-7-8 0-15 1-21 4-6 2-10 6-14 10-9 10-13 22-13 36s4 26 13 35c8 10 20 15 35 15zm137 0c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-22 11-38 11-20 0-35-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 13-13 28-19 48-19 19 0 35 6 47 19s17 29 17 49v8h-109c2 12 6 22 15 30 8 8 19 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-14 28h88c-2-11-6-21-14-28-8-8-18-11-30-11zm105 116h-19V283h19v185zm51 0h-20V283h20v185zm89-16c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19 11 13 17 29 17 49v8h-109c2 12 6 22 14 30 9 8 19 12 32 12zm-1-100c-12 0-22 3-31 11-7 7-12 17-14 28h89c-2-11-7-21-14-28-8-8-18-11-30-11zm105-16v20c5-6 10-11 17-16 7-4 15-6 23-6 9 0 17 1 23 3 6 3 12 6 16 11 11 11 16 25 16 43v77h-19v-77c0-12-4-21-10-29-7-7-16-10-27-10s-20 3-28 11c-7 7-11 17-11 29v76h-19V336h19zm185 116a40 40 0 0037-26h21c-4 13-12 24-22 32-11 8-25 12-40 12-19 0-34-7-46-20a69 69 0 01-18-48c0-20 6-36 18-49s27-19 46-19c15 0 29 4 40 12 10 8 18 18 22 31h-21c-3-7-8-14-15-18-6-5-13-7-22-7-8 0-15 1-21 4-6 2-11 6-15 10-8 10-12 22-12 36s4 26 12 35c9 10 21 15 36 15zm137 0c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19s17 29 17 49v8h-109c2 12 6 22 15 30 8 8 18 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-15 28h89c-2-11-6-21-14-28-8-8-18-11-30-11zM412 454c0 16-7 19-18 19h-53c-11 0-20-4-27-13L130 213h-2v242c0 13-6 18-18 18H52c-14 0-20-3-20-18V62c0-16 7-19 20-19h52c13 0 19 3 26 13l184 248h1V61c0-14 7-18 19-18h60c16 0 17 8 17 19v392h1zm197 4c0 7-5 14-14 14h-71c-9 0-14-7-14-14V56c0-8 5-15 14-15h71c9 0 14 7 14 14v403zm415-380l-18 52c-2 6-5 9-9 9l-8-2c-33-16-58-21-87-21-65 0-106 49-106 140 0 98 47 140 107 140 29 0 55-5 84-17l9-3c6 0 9 3 11 10l16 46 2 10c0 6-3 11-12 14-42 16-77 24-125 24-131 0-197-87-197-221S772 32 896 32c45 0 82 9 118 25 9 4 12 8 12 12l-2 9zm336-37c13 0 17 6 16 15l-6 50c-1 13-9 15-24 15h-149v93h140c14 0 19 7 19 17v45c0 12-7 18-18 18h-141v98h161c11 0 18 5 18 17v46c0 11-6 17-17 17h-240c-14 0-21-4-21-19V59c0-11 6-18 16-18h246z" fill="currentColor"></path></svg></a><div class="Header-module--wrapper--2e13D"><div class="Header-module--search--2nfnz"><form id="global-nav-search-form" role="search" action="https://cks.nice.org.uk/search" class="Search-module--search--2wNll"><label class="Search-module--label--1rrog" for="autocomplete">Search CKS…</label><div class="Autocomplete-module--ac--2PqiF"><div class="autocomplete__wrapper"><input type="search" id="autocomplete" name="q" class="autocomplete__input autocomplete__input--default" placeholder="Search CKS…" data-hj-allow="" maxLength="512" value=""/></div></div><button class="Search-module--button--2FbnI" type="submit" aria-label="Perform search"><svg width="1em" height="1em" viewBox="0 0 512 512" fill="none" class="Search-module--icon--2JB42" aria-hidden="true" focusable="false"><path d="M83.784 476.472L197.112 363.16c30.144 20.32 65.056 30.528 100.032 30.528 45.904 0 91.776-17.488 126.8-52.528 70.064-70.064 70.064-183.584 0-253.616C388.936 52.504 343.048 35 297.144 35c-45.904 0-91.808 17.504-126.848 52.528-61.696 61.696-68.976 157.12-21.968 226.864L35 427.752l48.784 48.72zm213.36-137.952c-33.168 0-64.352-12.896-87.792-36.368-48.416-48.448-48.416-127.2 0-175.616 23.44-23.44 54.64-36.352 87.792-36.352s64.336 12.912 87.776 36.368c23.44 23.456 36.384 54.64 36.384 87.792s-12.928 64.352-36.384 87.792c-23.456 23.472-54.624 36.368-87.776 36.368v.016z" fill="currentColor"></path></svg></button></form></div><button class="Header-module--mobileMenuBtn--1LgyL" id="header-menu-button" type="button" aria-controls="header-menu" aria-expanded="false" aria-haspopup="menu" aria-label="Expand site menu">Menu</button></div></div><div id="header-menu" class="Nav-module--wrapper--2_xng Nav-module--wrapperWithSubLinks--3PUfX"><nav class="Nav-module--nav--2aQpa" aria-label="primary navigation"><div class="Nav-module--menuWrapper--2fp8S"><ul class="Nav-module--menuList--264L-" aria-labelledby="header-menu-button"><li><a href="https://pathways.nice.org.uk/" class="Nav-module--link--3JzDA">NICE Pathways</a></li><li><a href="https://www.nice.org.uk/guidance" class="Nav-module--link--3JzDA">NICE guidance</a></li><li><a href="https://www.nice.org.uk/standards-and-indicators" class="Nav-module--link--3JzDA">Standards and indicators</a></li><li><a href="https://www.evidence.nhs.uk/" class="Nav-module--link--3JzDA">Evidence search</a></li><li><a href="https://bnf.nice.org.uk/" class="Nav-module--link--3JzDA"><abbr title="British National Formulary">BNF<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">British National Formulary</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">British National Formulary</span></a></li><li><a href="https://bnfc.nice.org.uk/" class="Nav-module--link--3JzDA"><abbr title="British National Formulary for Children">BNFC<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">British National Formulary for Children</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">British National Formulary for Children</span></a></li><li><a href="../../../../index.html" aria-current="true" class="Nav-module--link--3JzDA"><abbr title="Clinical Knowledge Summaries">CKS<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">Clinical Knowledge Summaries</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">Clinical Knowledge Summaries</span></a><div class="SubNav-module--wrapper--yAXWY"><ul class="SubNav-module--list--1K9bK" aria-label="CKS links"><li class="SubNav-module--imageLink--3xwIS"><a href="../../../../index.html" class="SubNav-module--link--39i23" aria-label="CKS - Home"><img src="data:image/svg+xml;base64,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" class="SubNav-module--image--uq-a2" alt=""/></a></li><li><a href="../../../index.html" class="SubNav-module--link--39i23" aria-label="Health topics A to Z">Health topics A to Z</a></li><li><a href="../../../../specialities/index.html" class="SubNav-module--link--39i23" aria-label="Specialities">Specialities</a></li><li><a href="../../../../whats-new/index.html" class="SubNav-module--link--39i23" aria-label="What&#x27;s new">What&#x27;s new</a></li><li><a href="../../../../about/index.html" class="SubNav-module--link--39i23" aria-label="About CKS">About CKS</a></li></ul></div></li><li><a href="https://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases" class="Nav-module--link--3JzDA">Journals and databases</a></li></ul></div></nav></div></header><aside class="CoronaMessage-module--wrapper--zRiaV" aria-label="COVID-19 Notice"><div class="CoronaMessage-module--container--36Biz"><p>Read about<!-- --> <a href="https://www.nice.org.uk/covid-19">our approach to COVID-19</a></p></div></aside></div></div><main class="Layout-module--main--1OIFf" id="content-start"><div class="container"><nav aria-label="Breadcrumbs" role="navigation"><ol class="breadcrumbs"><li class="breadcrumbs__crumb"><a href="https://www.nice.org.uk/">NICE</a></li><li class="breadcrumbs__crumb"><a href="../../../../index.html">CKS</a></li><li class="breadcrumbs__crumb"><a href="../../../index.html">Health topics A to Z</a></li><li class="breadcrumbs__crumb"><a href="../../index.html">Vitamin D deficiency in children</a></li><li class="breadcrumbs__crumb"><a href="../index.html">Management</a></li><li class="breadcrumbs__crumb"><span>Scenario: Management of vitamin D deficiency or insufficiency</span></li></ol></nav><script type="application/ld+json">{"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://www.nice.org.uk/","name":"NICE"}},{"@type":"ListItem","position":2,"item":{"@id":"/","name":"CKS"}},{"@type":"ListItem","position":3,"item":{"@id":"/topics/","name":"Health topics A to Z"}},{"@type":"ListItem","position":4,"item":{"@id":"/topics/vitamin-d-deficiency-in-children/","name":"Vitamin D deficiency in children"}},{"@type":"ListItem","position":5,"item":{"@id":"/topics/vitamin-d-deficiency-in-children/management/","name":"Management"}},{"@type":"ListItem","position":6,"item":{"name":"Scenario: Management of vitamin D deficiency or insufficiency"}}]}</script><div class="page-header"><h1 class="page-header__heading"><span class="page-header__pre-heading">Vitamin D deficiency in children: </span><span>Scenario: Management of confirmed vitamin D deficiency or insufficiency in children and young people</span></h1><p class="page-header__lead"><span>Last revised in December 2020</span></p></div><p class="visually-hidden">Covers the management of children and young people with confirmed vitamin D deficiency or insufficiency.</p><div class="ChapterContents-module--wrapper--3ONbu"><div class="ChapterContents-module--menu--3Epka"><nav class="stacked-nav" aria-label="Vitamin D deficiency in children chapters"><ul class="stacked-nav__list"><li class="stacked-nav__list-item" data-tracking="Summary"><a aria-current="false" href="../../index.html"><span class="stacked-nav__content-wrapper">Summary</span></a></li><li class="stacked-nav__list-item" data-tracking="Have I got the right topic?"><a aria-current="false" href="../../have-i-got-the-right-topic/index.html"><span class="stacked-nav__content-wrapper">Have I got the right topic?</span></a></li><li class="stacked-nav__list-item" data-tracking="How up-to-date is this topic"><a aria-current="false" href="../../how-up-to-date-is-this-topic/index.html"><span class="stacked-nav__content-wrapper">How up-to-date is this topic</span></a></li><li class="stacked-nav__list-item" data-tracking="Goals and outcome measures"><a aria-current="false" href="../../goals-outcome-measures/index.html"><span class="stacked-nav__content-wrapper">Goals and outcome measures</span></a></li><li class="stacked-nav__list-item" data-tracking="Background information"><a aria-current="false" href="../../background-information/index.html"><span class="stacked-nav__content-wrapper">Background information</span></a></li><li class="stacked-nav__list-item" data-tracking="Diagnosis"><a aria-current="false" href="../../diagnosis/index.html"><span class="stacked-nav__content-wrapper">Diagnosis</span></a></li><li class="stacked-nav__list-item" data-tracking="Management"><a aria-current="false" href="../index.html"><span class="stacked-nav__content-wrapper">Management</span></a><ul class="stacked-nav__nested"><li class="stacked-nav__list-item" data-tracking="Management | Scenario: Management of vitamin D deficiency or insufficiency"><a aria-current="true" class="" href="index.html"><span class="stacked-nav__content-wrapper">Scenario: Management of vitamin D deficiency or insufficiency</span></a></li><li class="stacked-nav__list-item" data-tracking="Management | Scenario: Prevention of vitamin D deficiency"><a aria-current="false" href="../prevention-of-vitamin-d-deficiency/index.html"><span class="stacked-nav__content-wrapper">Scenario: Prevention of vitamin D deficiency</span></a></li></ul></li><li class="stacked-nav__list-item" data-tracking="Prescribing information"><a aria-current="false" href="../../prescribing-information/index.html"><span class="stacked-nav__content-wrapper">Prescribing information</span></a></li><li class="stacked-nav__list-item" data-tracking="Supporting evidence"><a aria-current="false" href="../../supporting-evidence/index.html"><span class="stacked-nav__content-wrapper">Supporting evidence</span></a></li><li class="stacked-nav__list-item" data-tracking="How this topic was developed"><a aria-current="false" href="../../how-this-topic-was-developed/index.html"><span class="stacked-nav__content-wrapper">How this topic was developed</span></a></li><li class="stacked-nav__list-item" data-tracking="References"><a aria-current="false" href="../../references/index.html"><span class="stacked-nav__content-wrapper">References</span></a></li></ul></nav></div><div class="ChapterContents-module--onThisPage--1333P"><nav class="ChapterOnThisPage-module--wrapper--2zc7n" aria-labelledby="on-this-page"><h2 class="ChapterOnThisPage-module--heading--2SdDN" id="on-this-page">On this page</h2><ol class="ChapterOnThisPage-module--rootList--2II70" aria-label="Jump links to section on this page"><li><a href="index.html#who-should-i-treat">Who should I treat?</a><ol aria-label="Sections within Who should I treat?" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-064">Basis for recommendation</a></li></ol></li><li><a href="index.html#how-should-i-treat">How should I treat?</a><ol aria-label="Sections within How should I treat?" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-dbe">Basis for recommendation</a></li></ol></li><li><a href="index.html#follow-up">Follow up</a><ol aria-label="Sections within Follow up" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-d43">Basis for recommendation</a></li></ol></li><li><a href="index.html#lifestyle-advice">Lifestyle advice</a><ol aria-label="Sections within Lifestyle advice" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-6ff">Basis for recommendation</a></li></ol></li></ol></nav></div><div class="ChapterContents-module--body--1XBoo"><section aria-labelledby="management-of-vitamin-d-deficiency-or-insufficiency" class="ChapterBody-module--wrapper--2HCfk "><h2 id="management-of-vitamin-d-deficiency-or-insufficiency" class="visually-hidden">Scenario: Management of confirmed vitamin D deficiency or insufficiency in children and young people</h2><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 510a18b7-b6df-4368-99e8-ba6bf90886c0 --><!-- begin field 8be94c00-3a5c-4a42-8a3d-acbc01595b47 --><p>From age 1 month to 18 years.</p><!-- end field 8be94c00-3a5c-4a42-8a3d-acbc01595b47 --><!-- end item 510a18b7-b6df-4368-99e8-ba6bf90886c0 --></div><section aria-labelledby="who-should-i-treat" class="ChapterBody-module--wrapper--2HCfk "><h3 id="who-should-i-treat">Who should be treated for vitamin D deficiency?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item c1b4e4cf-69e7-45fb-8e6b-e17b1eff6de6 --><!-- begin field 42a0213c-a267-489c-8366-f04c5c020487 --><ul><li><strong><a class="topic-reference internal-reference" href="index.html#how-should-i-treat">Treat&nbsp;</a>for vitamin D deficiency if serum 25-hydroxyvitamin D (25[OH]D) levels are </strong>less than 25 nmol/L.</li><li><strong>If serum 25(OH)D levels are above 25 nmol/L, </strong>provide reassurance and advise on <a class="topic-reference internal-reference" href="../prevention-of-vitamin-d-deficiency/index.html#prevention">measures to prevent vitamin D deficiency</a>.<ul><li>If the child or young person has musculoskeletal symptoms (such as muscle pain or weakness) despite adequate serum 25(OH)D levels, consider an <em>alternative diagnosis</em>.</li></ul></li><li><strong>If serum 25(OH)D levels are in the range of </strong><strong>25–50 nmol/L:</strong><ul><li>Advise on <a class="topic-reference internal-reference" href="../prevention-of-vitamin-d-deficiency/index.html#prevention">measures to prevent vitamin D deficiency</a>.</li><li>Retesting is not normally required if the child or young person is asymptomatic and compliant with preventative measures.</li></ul></li><li><strong>Always consider the need for referral or seeking specialist advice, for example if the child or young person:</strong><ul><li>Is suspected to have a serious underlying condition (such as cancer) — refer appropriately.</li><li>Has <a class="topic-reference internal-reference" href="../../diagnosis/who-to-test/index.html">clinical features</a> of rickets (such as bone deformities) — refer to a paediatrician.</li><li>Has <a class="topic-reference internal-reference" href="../../diagnosis/who-to-test/index.html">other musculoskeletal symptoms&nbsp;</a>(such as muscle pain or weakness).</li><li>Has hypocalcaemia:<ul><li>If symptomatic (irritability, tetany, seizures, or other neurological abnormalities), refer immediately to A&E.</li><li>If asymptomatic, seek specialist advice from a paediatrician.</li></ul></li><li>Has a malabsorption disorder (for example Crohn's disease) or other <a class="topic-reference internal-reference" href="../../background-information/causes/index.html">condition</a> known to cause vitamin D deficiency.</li><li>Is taking a <a class="topic-reference internal-reference" href="../../background-information/causes/index.html">drug</a> that can increase the risk of vitamin D deficiency (such as some antiepileptics or oral corticosteroids). </li></ul></li></ul><!-- end field 42a0213c-a267-489c-8366-f04c5c020487 --><!-- end item c1b4e4cf-69e7-45fb-8e6b-e17b1eff6de6 --></div><section aria-labelledby="basis-for-recommendation-064" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-064">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 06402e1b-7ebb-479b-904b-f4151f2b026c --><!-- begin field ad9819bd-ab9d-4a7d-88c3-de6d6c88e59c --><h5>Managing serum 25-hydroxyvitamin D (25[OH]D) levels less than 25 nmol/L</h5><ul><li>This recommendation is based on expert opinion in the National Osteoporosis Society (NOS) guideline <em>Vitamin D and bone health: a practical clinical guideline for management in children and young people </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>] and the Scientific Advisory Committee on Nutrition (SACN) guideline<em> Vitamin D and Health </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">SACN, 2016</a>].</li></ul><h5>Managing serum 25(OH)D levels in the range of 25–50 nmol/L</h5><ul><li>The recommendation to advise on measures to prevent vitamin D deficiency is based on expert opinion in the NOS guideline, which recommends advising on safe sun exposure, advising on supplemental vitamin D, and ensuring adequate dietary calcium intake for children and young people with serum 25(OH)D in the range of 25–50 nmol/L<em> </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>].</li></ul><h5>Managing serum 25(OH)D levels above 50 nmol/L</h5><ul><li>NOS recommends providing reassurance and advising on safe sun exposure and dietary intake of vitamin D for children and young people with serum 25(OH)D above 50 nmol/L<em> </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>].</li><li>The recommendation to consider an alternative diagnosis if there are musculoskeletal symptoms at serum 25(OH)D above 50 nmol/L is extrapolated from the NOS guideline, which states that if a child or young person treated for vitamin D deficiency remains symptomatic despite a satisfactory 25(OH)D concentration, symptoms are unlikely to be related to vitamin D deficiency<em> </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>] .</li></ul><h5>Always considering the need for referral or seeking specialist advice</h5><ul><li>The recommendation to consider referral or seeking specialist advice in certain cases is largely based on the NOS guideline, which lists repeated hypocalcaemia, underlying medical disorders, and deformities related to rickets as indications for secondary care referral.</li><li>The other referral criteria are based on what CKS considers to be good clinical practice.</li></ul><!-- end field ad9819bd-ab9d-4a7d-88c3-de6d6c88e59c --><!-- end item 06402e1b-7ebb-479b-904b-f4151f2b026c --></div></section></section><section aria-labelledby="how-should-i-treat" class="ChapterBody-module--wrapper--2HCfk "><h3 id="how-should-i-treat">How should I treat a child or young person with vitamin D deficiency?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item aedca9f5-6390-42be-87dc-00b35895b687 --><!-- begin field 4d80b175-94e9-442f-80d3-24334210c4f1 --><ul><li><strong>Consider the need for referral or seeking specialist advice.</strong><ul><li><strong>Refer to an appropriate specialist (using clinical judgement to decide on the urgency)</strong> if a serious underlying condition, such as cancer or a malabsorption disorder (for example Crohn's disease), is suspected. See the sections on <a class="topic-reference internal-reference" href="../../background-information/causes/index.html">Causes</a> and <a class="topic-reference internal-reference" href="../../diagnosis/differential-diagnosis/index.html">Differential diagnosis</a>.</li><li><strong>Refer to a paediatrician</strong> if the child or young person has <a class="topic-reference internal-reference" href="../../diagnosis/who-to-test/index.html">clinical features</a><em> </em>of rickets (such as bone deformities).</li><li><strong>Refer or seek specialist advice (depending on clinical judgement)</strong> if the child or young person:<ul><li>Has hypocalcaemia — if symptomatic (irritability, tetany, seizures, or other neurological abnormalities), arrange immediate referral to A&E; if asymptomatic, seek specialist advice from a paediatrician.</li><li>Has a fragility fracture, documented osteoporosis, or high fracture risk, or is being treated with an antiresorptive drug for bone disease.</li><li>Has raised parathyroid hormone levels.</li><li>Has a malabsorption disorder (for example Crohn's disease) or other <a class="topic-reference internal-reference" href="../../background-information/causes/index.html">condition</a> known to cause vitamin D deficiency.</li><li>Has a co-existing condition associated with increased sensitivity to vitamin D (such as sarcoidosis, tuberculosis, lymphoma, or primary hyperparathyroidism).</li><li>Is taking a <a class="topic-reference internal-reference" href="../../background-information/causes/index.html">drug</a> that can increase the risk of vitamin D deficiency (such as some antiepileptics or oral corticosteroids) or the risk of vitamin D toxicity (such as a thiazide diuretic or digoxin). </li></ul></li></ul></li><li><strong>Choose the most appropriate vitamin D preparation for the person.</strong><ul><li>Vitamin D<sub>2</sub> is recommended for strict vegans as it is derived from plant sources. There are also vitamin D preparations for people with peanut or soya allergy and for people with halal or kosher requirements.</li><li>See the section on <a class="topic-reference internal-reference" href="../../prescribing-information/high-dose-vitamin-d/index.html#available-products">Available preparations</a> for more information.</li></ul></li><li><strong>Prescribe oral high-dose vitamin D treatment, </strong>followed by <a class="topic-reference internal-reference" href="../prevention-of-vitamin-d-deficiency/index.html#prevention">daily supplemental doses</a><em>.</em><ul><li>The doses currently advised in the British National Formulary (BNF) for Children are:<ul><li><strong>Age 1–6 months:</strong> 3,000 international units (IU) daily for 8–12 weeks.</li><li><strong>Age 6 months–12 years:</strong> 6,000 IU daily for 8–12 weeks.</li><li><strong>Age 12–18 years:</strong> 10,000 IU daily for 8–12 weeks.</li></ul></li><li>These may need to be changed depending on the availability of other vitamin D preparations and evidence of alternative dosing regimens.</li></ul></li><li><strong>Calculate</strong><strong> dietary calcium intake.</strong><ul><li>Several online calcium calculators are available, such as the <a href="http://www.cgem.ed.ac.uk/research/rheumatological/calcium-calculator" data-hyperlink-id="41e58e6d-f38b-44c4-abdd-a98c015b005d">Institute of Genetics and Molecular Medicine calcium calculator</a>.</li><li>The recommended daily intake of calcium is:<ul><li><strong>Age younger than 12 months</strong>: 525 mg (13.1 mmol).</li><li><strong>Age 1–3 years</strong>: 350 mg (8.8 mmol).</li><li><strong>Age 4–6 years:  </strong>450 mg (11.3 mmol)<strong>.</strong></li><li><strong>Age 7–10 years</strong>: 550 mg (13.8 mmol).</li><li><strong>Age 11–18 years (boys): </strong>1000 mg (25.0 mmol)<strong>.</strong></li><li><strong>Age 11–18 years (girls): </strong>800 mg (20.0 mmol).</li></ul></li><li><strong>If the child or young person has an inadequate dietary calcium intake,</strong> advise on dietary measures to correct this.<ul><li>See the British Dietetic Association (BDA) factsheet on <a href="https://www.bda.uk.com/foodfacts/Calcium.pdf" data-hyperlink-id="814d76fe-4c61-4ff2-b6b3-a98c015b007a">Calcium</a> (available at <a href="https://www.bda.uk.com/" data-hyperlink-id="716f870e-e4c1-4e9a-b3ee-a98c015b00e7">www.bda.uk.com</a>) for information on how the recommended daily calcium intake can be achieved.</li></ul></li><li><strong>If they are unable or unwilling to increase their dietary calcium, </strong>consider the need for <a class="topic-reference internal-reference" href="../../prescribing-information/calcium-supplements/index.html#available-preparations">supplemental calcium</a> (in addition to high-dose vitamin D) — consider seeking specialist advice.<ul><li>The supplemental calcium doses currently advised in the BNF for Children are:<ul><li><strong>Age 1 month – 4 years:</strong> 0.25 mmol (10 mg) per kg four times daily, adjusted to response.</li><li><strong>Age 5 – 12 years:</strong> 0.2 mmol (8 mg) per kg four times daily, adjusted to response.</li><li><strong>Age 12–18 years:</strong> 10 mmol (400 mg) four times daily, adjusted to response.</li></ul></li><li>Combined calcium and vitamin D preparations (such as Calcichew D3®) are available; however, they are not recommended for people on high-dose vitamin D treatment because they contain very low levels of vitamin D (200–400 units per tablet) and may result in high dosing of calcium, thereby increasing the risk of hypercalcaemia.</li></ul></li></ul></li><li><strong>Advise the child and/or the parents/carers:</strong><ul><li>To seek medical advice if they develop any <a class="topic-reference internal-reference" href="../../prescribing-information/high-dose-vitamin-d/index.html#adverse-effects">adverse effects</a> during treatment with high-dose vitamin D, such as nausea and vomiting.</li><li>On <a class="topic-reference internal-reference" href="index.html#lifestyle-advice">lifestyle measures</a> to reduce the risk of recurrence.</li></ul></li><li><strong><a class="topic-reference internal-reference" href="index.html#follow-up">Follow up</a> </strong><strong>the child or young person </strong>to ensure that vitamin D deficiency has been treated and to assess for <a class="topic-reference internal-reference" href="../../prescribing-information/high-dose-vitamin-d/index.html#adverse-effects">vitamin D toxicity</a><em> </em>(although this is unlikely at the recommended doses).<ul><li>Be aware that vitamin D treatment can unmask previously undiagnosed primary hyperparathyroidism.</li></ul></li></ul><!-- end field 4d80b175-94e9-442f-80d3-24334210c4f1 --><!-- end item aedca9f5-6390-42be-87dc-00b35895b687 --></div><section aria-labelledby="basis-for-recommendation-dbe" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-dbe">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item dbe8ca60-b559-4626-bcf3-b21a7709f493 --><!-- begin field 404b35b5-463e-44e7-bb8c-a7cb34b1530a --><p>These recommendations are largely based on the National Osteoporosis Society (NOS) guideline<em> Vitamin D and bone health: a practical clinical guideline for management in children and young people </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>], local vitamin D guidelines issued by Barts and The London School of Medicine and Dentistry [<a class="bibliography-reference internal-reference" href="../../references/index.html">Hull and Anastasiadis, 2011</a>] and the Northamptonshire Prescribing Advisory Group [<a class="bibliography-reference internal-reference" href="../../references/index.html">Nene Clinical Commissioning Group NHS, 2016</a>], the British National Formulary (BNF) for Children [<a class="bibliography-reference internal-reference" href="../../references/index.html">BNF for Children, 2017</a>], and review articles on vitamin D deficiency [<a class="bibliography-reference internal-reference" href="../../references/index.html">Pearce and Cheetham, 2010</a>] <strong> </strong>[<a class="bibliography-reference internal-reference" href="../../references/index.html">Musson and Collin, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">BMJ, 2016</a>].</p><h5>Arranging referral </h5><ul><li>The recommendation to arrange referral if a serious underlying cause is suspected is based on what CKS considers to be good clinical practice.</li><li>The recommendation to arrange referral if there are clinical features of rickets is based on expert opinion in the NOS guideline [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>].</li><li>For other groups, the recommendation to arrange referral or seek specialist advice aims to ensure that the appropriate dose, duration, and treatment regimen of vitamin D are given. For example:<ul><li>Children and young people with malabsorption disorders or chronic liver disease would need higher doses of vitamin D (for example ergocalciferol tablets up to 40,000 international units [IU] a day for children aged 12–18 years [or up to 25,000 IU for younger children]) [<a class="bibliography-reference internal-reference" href="../../references/index.html">BNF for Children, 2017</a>].</li><li>Children and young people with kidney disease that is severe enough to impair the hydroxylation of vitamin D may require treatment with a short-acting, potent vitamin D analogue, such as alphacalcidol or calcitriol (specialist initiation only) [<a class="bibliography-reference internal-reference" href="../../references/index.html">BNF for Children, 2017</a>].</li><li>Children and young people with co-existing conditions associated with increased sensitivity to vitamin D are at increased risk of vitamin D toxicity and therefore need lower doses of vitamin D and more frequent monitoring [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">BNF for Children, 2017</a>].</li></ul></li></ul><h5>Choosing the most appropriate vitamin D preparation</h5><ul><li>The current consensus is that vitamin D<sub>3</sub> raises serum vitamin D concentrations more effectively than vitamin D<sub>2</sub> (due to higher affinities for liver enzymes, plasma vitamin D binding protein, and vitamin D receptors) [<a class="bibliography-reference internal-reference" href="../../references/index.html">UKMi, 2016</a>].<ul><li>Results from studies (identified by SACN) that compared the effectiveness of vitamin D<sub>2</sub> and vitamin D<sub>3</sub> in raising serum 25-hydroxyvitamin D (25[OH]D) concentrations have been inconsistent, but most of the evidence supports the suggestion that vitamin D<sub>3</sub> is more effective than vitamin D<sub>2</sub> in raising serum 25(OH)D concentrations [<a class="bibliography-reference internal-reference" href="../../references/index.html">SACN, 2016</a>].</li><li>Expert opinion in the NOS guideline is that both forms of vitamin D have been shown to cure rickets [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>].</li></ul></li><li>Vitamin D<sub>2</sub> is recommended for strict vegans because it is derived from plant sources, unlike vitamin D<sub>3</sub> which is derived from animal sources [<a class="bibliography-reference internal-reference" href="../../references/index.html">UKMi, 2016</a>].</li></ul><h5>Vitamin D treatment regimen</h5><ul><li>The recommended treatment regimens are based on the BNF for Children [<a class="bibliography-reference internal-reference" href="../../references/index.html">BNF for Children, 2017</a>], which states that initial high doses of vitamin D should be reduced to supplemental doses after 8–12 weeks due to the significant risk of hypercalcaemia.</li></ul><h5>Ensuring adequate calcium intake </h5><ul><li>Expert opinion in the NOS guideline is that many children with vitamin D deficiency will also be calcium deficient and may therefore benefit from advice on dietary calcium intake and, in some cases, calcium supplements (in addition to high-dose vitamin D) [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>]. The BNF for Children recommends calcium supplements if there is hypocalcaemia or evidence of poor dietary calcium intake [<a class="bibliography-reference internal-reference" href="../../references/index.html">BNF for Children, 2017</a>].</li><li>The recommended daily intake values of dietary calcium are taken from the NOS guideline<em><strong> </strong></em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>] and are based on the Department of Health <em>Dietary values for food, energy and nutrients for United Kingdom</em>: r<em>eport of the panel on dietary reference values of the Committee on Medical Aspects of Food Policy</em>.</li><li>The recommendation to consider the need for supplemental calcium only when an adequate dietary intake of calcium cannot be achieved is extrapolated from expert opinion in the National Osteoporosis Guideline Group (NOGG) guideline <em>Osteoporosis: clinical guideline for prevention and treatment</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">NOGG, 2016</a>], which states that it may be prudent to increase dietary calcium intake and use vitamin D alone where the use of calcium and vitamin D supplementation might otherwise be considered. In their expert opinion, compliance and persistence with calcium-containing supplements is poor [<a class="bibliography-reference internal-reference" href="../../references/index.html">NOGG, 2016</a>], possibly due to the unpalatability of the calcium component [<a class="bibliography-reference internal-reference" href="../../references/index.html">Hull and Anastasiadis, 2011</a>].  </li><li>The recommendation to consider seeking specialist advice if supplemental calcium is being considered is based on what CKS considers to be good clinical practice, as there is an increased risk of hypercalcaemia with concurrent high-dose vitamin D treatment.</li><li>The recommendation on calcium and vitamin D combination products is extrapolated from expert opinion in the NOS vitamin D guideline for adults [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2013</a>], which states that calcium and vitamin D combination products should not be used as a source of vitamin D during high-dose vitamin D treatment. Expert opinion in the Northamptonshire Prescribing Advisory Group vitamin D guideline for children and young people is that calcium and vitamin D combination products are unsuitable for treating vitamin D deficiency because they contain sub-therapeutic quantities of vitamin D and may also cause hypercalcaemia [<a class="bibliography-reference internal-reference" href="../../references/index.html">Nene Clinical Commissioning Group NHS, 2016</a>].</li></ul><h5>Giving lifestyle advice</h5><ul><li>This recommendation is based on expert opinion in the NOS guideline [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>] and in a review article on vitamin D deficiency [<a class="bibliography-reference internal-reference" href="../../references/index.html">BMJ, 2016</a>].</li></ul><h5>Following up to ensure vitamin D repletion and to assess for vitamin D toxicity</h5><ul><li>This recommendation is based on expert opinion in the NOS guideline [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>], guidelines issued by the UK Medicines Information (UKMi) [<a class="bibliography-reference internal-reference" href="../../references/index.html">UKMi, 2016</a>] and Barts and The London School of Medicine and Dentistry [<a class="bibliography-reference internal-reference" href="../../references/index.html">Hull and Anastasiadis, 2011</a>], and review articles on vitamin D deficiency [<a class="bibliography-reference internal-reference" href="../../references/index.html">Pearce and Cheetham, 2010</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Musson and Collin, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">BMJ, 2016</a>].</li><li>The NOS vitamin D guideline for adults states that the aims of monitoring people on high-dose vitamin D treatment are to detect people [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2013</a>]:<ul><li>Who remain deficient after loading.</li><li>Who become deficient during maintenance.</li><li>In whom vitamin D treatment uncovers sub-clinical primary hyperparathyroidism.</li></ul></li><li>The Scientific Advisory Committee on Nutrition (SACN) found insufficient data to specify a safe upper limit for single doses of vitamin D in children and young people. However, the limited data identified suggests that vitamin D toxicity could occur in infants at doses of 15,000 micrograms (600,000 IU) or more [<a class="bibliography-reference internal-reference" href="../../references/index.html">SACN, 2016</a>]. </li></ul><!-- end field 404b35b5-463e-44e7-bb8c-a7cb34b1530a --><!-- end item dbe8ca60-b559-4626-bcf3-b21a7709f493 --></div></section></section><section aria-labelledby="follow-up" class="ChapterBody-module--wrapper--2HCfk "><h3 id="follow-up">How should I follow up a child or young person on high-dose vitamin D treatment?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 5cf9e4f1-a985-475b-b030-2bca3d3d2f55 --><!-- begin field 0e4572f8-b38e-4ad5-a53d-db4256e26c11 --><ul><li><strong>At the end of treatment with high-dose vitamin D:</strong><ul><li>Check adjusted serum calcium levels. Consider checking calcium levels more regularly (for example every 1–2 weeks in the first months of treatment) in children and young people receiving calcium supplements in addition to high-dose vitamin D treatment.<ul><li><strong>If hypercalcaemia is identified, </strong>assess the person's state of hydration, and consider admission if the person is dehydrated. If the person is taking a calcium supplement, advise that it should be stopped.</li><li><strong>If calcium levels are normal, </strong>do not recommend long-term calcium supplements. If the person is taking a calcium supplement, advise that it should be stopped.</li><li><strong>If hypocalcaemia is identified, </strong>refer immediately to A&E if the person is symptomatic (irritability, tetany, seizures, or other neurological abnormalities), <em>or </em>seek specialist advice from a paediatrician if the person is asymptomatic.</li></ul></li><li>Check serum phosphate and alkaline phosphatase (ALP) levels.<ul><li>Refer to secondary care if there is persisting low serum phosphate or low/high ALP.</li></ul></li></ul></li><li><strong>After 3–6 months of treatment with high-dose vitamin D, </strong>check serum 25-hydroxyvitamin D (25[OH]D) levels. <ul><li><strong>If 25(OH)D levels are greater than 50 nmol/L and bone profile (calcium, phosphate, and ALP) is normal:</strong><ul><li>Advise that the person should take a daily vitamin D supplement throughout the year. See the section on <a class="topic-reference internal-reference" href="../prevention-of-vitamin-d-deficiency/index.html#prevention">Preventing vitamin D deficiency</a> for more information.</li></ul></li><li><strong>If 25(OH)D levels are below 50 nmol/L, </strong>refer to secondary care for consideration of possible causes, including poor compliance with treatment, <a class="topic-reference internal-reference" href="../../prescribing-information/high-dose-vitamin-d/index.html#drug-interactions">drug interactions</a>, or an <a class="topic-reference internal-reference" href="../../background-information/causes/index.html">underlying disease</a><strong><em> </em></strong>(such as renal disease, liver disease, or malabsorption).<ul><li><strong>Management options for poor compliance include </strong>giving a large dose of vitamin D (for example 300,000 international units [IU]) as a single or divided dose for people aged 12–18 years.</li></ul></li><li><strong>If symptoms and signs have not improved despite satisfactory 25(OH)D levels, </strong>consider an <a class="topic-reference internal-reference" href="../../diagnosis/differential-diagnosis/index.html">alternative diagnosis</a>.</li></ul></li></ul><!-- end field 0e4572f8-b38e-4ad5-a53d-db4256e26c11 --><!-- end item 5cf9e4f1-a985-475b-b030-2bca3d3d2f55 --></div><section aria-labelledby="basis-for-recommendation-d43" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-d43">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item d43f72c3-1aab-4234-9d8f-8dd5b2d553a8 --><!-- begin field 912964c2-4e4a-492b-b9bf-67b81770e8eb --><h5>Checking serum calcium, phosphate, and alkaline phosphatase (ALP) levels</h5><ul><li><p>The National Osteoporosis Society (NOS) guideline <em>Vitamin D and bone health: a practical clinical guideline for management in children and young people </em>recommends repeating bone profile at the end of a course of high-dose vitamin D treatment [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>]. This recommendation is in line with expert opinion in local vitamin D guidelines [<a class="bibliography-reference internal-reference" href="../../references/index.html">Camden Clinical Commissioning Group NHS, 2014</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">NHS Wales, 2014</a>], which recommend checking blood profile after 3 months of completing high-dose vitamin D treatment.</p></li><li>Expert opinion in the British National Formulary (BNF) for Children [<a class="bibliography-reference internal-reference" href="../../references/index.html">BNF for Children, 2017</a>] and in local vitamin D guidelines [<a class="bibliography-reference internal-reference" href="../../references/index.html">Hull and Anastasiadis, 2011</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Camden Clinical Commissioning Group NHS, 2014</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">NHS Wales, 2014</a>] is that serum calcium levels should be checked more regularly in children and young people who are also receiving calcium supplements, to determine how long calcium supplementation is needed and to reduce the risk of hypercalcaemia.<ul><li>One expert reviewer of this CKS topic suggests that there is good evidence to support this recommendation but recognised that this more regular blood testing does not happen in clinical practice. CKS therefore recommends considering the need for more regular checks in this group of people.</li></ul></li><li>The recommendation on how to manage serum phosphate and ALP results is based on expert opinion in the NOS guideline for children and young people [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>].</li><li>The recommendations on how to manage serum calcium results are based on what CKS considers to be good clinical practice.</li></ul><h5>Checking serum 25-hydroxyvitamin D (25[OH]D) levels</h5><ul><li><p>The NOS guideline <em>Vitamin D and bone health: a practical clinical guideline for management in children and young people </em>also<em> </em>recommends repeating vitamin D tests at the end of a course of high-dose vitamin D treatment [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>].</p></li><li>The recommendation to do this after 3–6 months of treatment is extrapolated from the NOS vitamin D guideline for adults [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2013</a>]. <ul><li>Based on evidence suggesting that a new steady state 25(OH)D level is reached after about 3 months of vitamin D treatment (6 months in another study), NOS recommends that a minimum of 3 months treatment must be given before checking 25(OH)D levels and that it may be more prudent to wait until after 6 months have passed [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2013</a>].</li></ul></li><li>The recommendations on how to manage serum 25(OH)D results is based on expert opinion in the NOS vitamin D guideline for children and young people [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Osteoporosis Society, 2015</a>].</li></ul><!-- end field 912964c2-4e4a-492b-b9bf-67b81770e8eb --><!-- end item d43f72c3-1aab-4234-9d8f-8dd5b2d553a8 --></div></section></section><section aria-labelledby="lifestyle-advice" class="ChapterBody-module--wrapper--2HCfk "><h3 id="lifestyle-advice">What lifestyle advice should I give a child or young person with vitamin D deficiency and/or their parents/carers? </h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 30314170-8dbe-4e21-84f1-6aef1079383f --><!-- begin field 9a34c4de-60ca-465f-a543-4b2173d8a715 --><p><strong>Give information and advice on:</strong></p><ul><li><strong>Safe sun exposure.</strong> Advise that:<ul><li>Exposing commonly uncovered areas of the skin (such as the forearms and hands) for short periods when in strong sunlight provides vitamin D. (Longer periods of exposure may be needed for those with darker skin.)<ul><li>Many young people will have experienced sunburn. They can use this experience to know what their skin looks like normally, how it reacts to sunlight, how long they can be exposed without risking sunburn, and how to protect their skin accordingly.</li><li>Advise that skin that is not usually exposed to sunlight (for example the back, abdomen and shoulders) is particularly likely to burn, so extra care is needed.</li></ul></li><li>Prolonged exposure to strong sunlight (for example leading to burning or tanning) does not lead to excess production of vitamin D, as a regulation mechanism exists to destroy excess vitamin D, but increases the risk of skin cancer.</li><li>Children younger than 6 months of age should be kept out of direct strong sunlight.</li><li>Between March and October in the UK, children and young people should protect their skin from burning by covering up with suitable clothing (such as long-sleeved tops, a broad-brimmed hat, or long skirts and trousers); seeking shade (especially between 11am and 3pm); and applying sunscreen, which should:<ul><li>Meet minimum standards for ultraviolet A (UVA) protection - the label should have the letters 'UVA' in a circle logo and should preferably state that it provides good UVA protection (for example at least '4-star UVA protection').</li><li>Provide at least sun protection factor (SPF) 15 to protect against UVB.</li><li>Be applied liberally and frequently, according to the manufacturer's instructions. If the sunscreen is applied too thinly, the amount of protection it gives is reduced.</li></ul></li><li>Sunbeds are not an effective method of protecting against vitamin D deficiency because they emit high levels of UVA, which do not contribute to vitamin D synthesis but increase the risk of skin cancer.</li></ul></li><li><strong>Dietary intake of vitamin D. </strong>Advise that:<ul><li>It is important to maintain dietary intake of vitamin D by taking vitamin D supplements, especially during the winter months, as it is difficult to obtain sufficient vitamin D from food sources alone because they are limited.</li><li>Rich sources include cod liver oil (this also contains vitamin A which can be harmful in high doses) and oily fish (such as salmon, mackerel, and sardines). Egg yolk, meat, offal, milk, mushrooms, and fortified foods (such as fat spreads and some breakfast cereals, yoghurts, and formula milk for infants and toddlers) contain small amounts.</li></ul></li><li><strong>Dietary intake of calcium. </strong>Advise that:<ul><li>It is also important to maintain dietary intake of calcium, as both calcium and vitamin D are needed to prevent long-term adverse effects on the bones.</li><li>Rich sources of calcium include dairy foods (milk, cheese, and yoghurts) and tinned sardines with bones. </li></ul></li><li><strong>Adherence to long-term supplementation.</strong><ul><li>Explain that long-term supplementation with vitamin D and, where necessary, calcium should be adhered to in order to prevent recurrence of deficiency and to maintain bone health.</li></ul></li><li><strong>Sources of additional information.</strong><ul><li>The British Dietetic Association has useful factsheets on <a data-hyperlink-id="e483c3eb-eb43-4f6c-9830-a98d009138a5" href="https://www.bda.uk.com/foodfacts/VitaminD.pdf">Vitamin D</a> and <a data-hyperlink-id="83ff22e8-98f2-416f-8bef-a98d0091390a" href="https://www.bda.uk.com/foodfacts/Calcium.pdf"><u>Calcium</u></a> (available at <a data-hyperlink-id="950abe59-f30b-42d0-93bb-a98d00913955" href="https://www.bda.uk.com/">www.</a><a data-hyperlink-id="7d710232-b3de-4564-8a74-a98d00913c9d" href="https://www.bda.uk.com/">bda.uk.com</a>)</li><li>The NHS website has a useful publication on <a data-hyperlink-id="64986ad6-d0d1-4a5e-b835-a98d00913e92" href="https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d/">Vitamins and minerals - Vitamin D</a> (available at <a data-hyperlink-id="8610ff92-26db-452f-b8b9-a98d00913eec" href="http://www.nhs.uk/pages/home.aspx">www.nhs.uk</a>).</li><li>The Met Office (<a data-hyperlink-id="45e430ef-da37-4f4f-b0fa-a98d00913f41" href="http://www.metoffice.gov.uk/"><u>www.metoffice.gov.uk</u></a>) provides information on the UV index, which is an indicator of the sun's strength for a given location, date, and time. This information, combined with skin type and behaviour, can be used to assess a person's risk of sunburn.</li></ul></li></ul><!-- end field 9a34c4de-60ca-465f-a543-4b2173d8a715 --><!-- end item 30314170-8dbe-4e21-84f1-6aef1079383f --></div><section aria-labelledby="basis-for-recommendation-6ff" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-6ff">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 6ff69fe9-1902-40d0-813c-9571450c3b67 --><!-- begin field f13684b4-3773-42d9-8167-ffc157b5b520 --><p>These recommendations are largely based on expert opinion in the National Institute for Health and Care Excellence (NICE) guidelines <em>Sunlight exposure: risks and benefits </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2016</a>]<em> </em>and<em> Vitamin D: increasing supplement use in at-risk groups </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2014</a>]<strong>, </strong>the Scientific Advisory Committee on Nutrition (SACN) guideline <em>Vitamin D and Heal</em><em>th</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">SACN, 2016</a>], and the Consensus Vitamin D position statement (which represents the unified views of the British Association of Dermatologists, Cancer Research UK, Diabetes UK, the Multiple Sclerosis Society, the National Heart Forum, the National Osteoporosis Society and the Primary Care Dermatology Society) [<a class="bibliography-reference internal-reference" href="../../references/index.html">BAD et al, 2010</a>].</p><ul><li>NICE does not describe the exact amount of sunlight exposure sufficient to stimulate cutaneous vitamin D production, but states that 'exposing commonly uncovered areas of skin, such as forearms and hands, for short periods when in strong sunlight provides vitamin D. (Longer periods of exposure may be needed for those with darker skin.)' [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2016</a>]. This is in line with recommendation in the SACN report and the Consensus Vitamin D position statement.<ul><li>SACN were unable to make any recommendations regarding the amount of sunlight exposure that would be needed during the summer months to maintain serum 25-hydroxyvitamin D (25[OH]D) levels of 25 nmol/L or greater during the winter months, as environmental and personal factors greatly affect cutaneous vitamin D production [<a class="bibliography-reference internal-reference" href="../../references/index.html">SACN, 2016</a>].</li><li>Expert opinion in the consensus position statement is that [<a class="bibliography-reference internal-reference" href="../../references/index.html">BAD et al, 2010</a>]:<ul><li>It is impractical to offer a one-size-fits-all recommendation for the amount of sun exposure that people need to make sufficient vitamin D, as this varies according to a number of factors (environmental, physical, and personal).</li><li>The time needed to make sufficient vitamin D is typically short and less than the amount of time needed for skin to redden and burn. Regularly going outside for a matter of minutes around midday without sunscreen should be enough.</li><li>When it comes to sun exposure, little and often is best, and the more skin that is exposed, the greater the chance of making enough vitamin D before burning.</li><li>People should get to know their own skin to understand how long they can spend outside before risking sunburn.</li></ul></li></ul></li><li>Expert opinion in the British Medical Journal (BMJ) Best Practice review article <em>Vitamin D deficiency</em> is that usually, exposure of the arms and legs (with sun protection on the face) for about 5 to 30 minutes (depending on degree of skin pigmentation, time of day, season, latitude, and age of the person) between 10 am and 3 pm twice a week is sufficient for vitamin D synthesis [<a class="bibliography-reference internal-reference" href="../../references/index.html">BMJ, 2016</a>].</li></ul><!-- end field f13684b4-3773-42d9-8167-ffc157b5b520 --><!-- end item 6ff69fe9-1902-40d0-813c-9571450c3b67 --></div></section></section></section></div></div></div><div class="BackToTop-module--wrapper--2Z0EU"><nav aria-labelledby="back-to-top-link" class="BackToTop-module--nav--1DPZ6"><a class="BackToTop-module--anchor--1Nia6" id="back-to-top-link" href="index.html#content-start"><div class="container"><svg width="1em" height="1em" viewBox="0 0 512 512" fill="none" class="icon" aria-hidden="true" focusable="false"><path d="M478.152 338.576c0 10.091-3.525 18.661-10.576 25.712l-21.424 21.424c-7.243 7.243-15.909 10.864-26 10.864-10.283 0-18.853-3.621-25.712-10.864L255.576 247.136 116.712 385.712c-6.859 7.243-15.429 10.864-25.712 10.864s-18.853-3.621-25.712-10.864l-21.424-21.424C36.621 357.429 33 348.859 33 338.576c0-10.091 3.621-18.757 10.864-26l186-186c7.051-7.051 15.621-10.576 25.712-10.576 9.909 0 18.576 3.525 26 10.576l185.712 186c7.243 7.243 10.864 15.909 10.864 26z" fill="currentColor"></path></svg> Back to top</div></a></nav></div></main><footer class="Footer-module--footer--2QrGZ"><div class="Footer-module--container--1iuoB"><a href="https://www.nice.org.uk/" class="Footer-module--logo--3DGKv" aria-label="Go to NICE home page"></a><nav class="Services-module--wrapper--2qOoE" aria-label="Our services"><ul class="Services-module--list--3SZQu"><li><a href="https://pathways.nice.org.uk/" class="Services-module--link--2y_1q">NICE Pathways</a></li><li><a href="https://www.nice.org.uk/guidance" class="Services-module--link--2y_1q">NICE guidance</a></li><li><a href="https://www.nice.org.uk/standards-and-indicators" class="Services-module--link--2y_1q">Standards and indicators</a></li><li><a href="https://www.evidence.nhs.uk/" class="Services-module--link--2y_1q">Evidence search</a></li><li><a href="https://bnf.nice.org.uk/" class="Services-module--link--2y_1q"><abbr title="British National Formulary">BNF<!-- --> <span class="Services-module--visuallyHidden--t9mfm">British National Formulary</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">British National Formulary</span></a></li><li><a href="https://bnfc.nice.org.uk/" class="Services-module--link--2y_1q"><abbr title="British National Formulary for Children">BNFC<!-- --> <span class="Services-module--visuallyHidden--t9mfm">British National Formulary for Children</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">British National Formulary for Children</span></a></li><li><a href="../../../../index.html" aria-current="true" class="Services-module--link--2y_1q"><abbr title="Clinical Knowledge Summaries">CKS<!-- --> <span class="Services-module--visuallyHidden--t9mfm">Clinical Knowledge Summaries</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">Clinical Knowledge Summaries</span></a></li><li><a href="https://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases" class="Services-module--link--2y_1q">Journals and databases</a></li></ul></nav><nav class="Pages-module--wrapper--30REl"><ul class="Pages-module--list--vvSk4"><li><a href="https://www.nice.org.uk/about">About NICE</a></li><li><a href="https://www.nice.org.uk/about/what-we-do/into-practice">Into practice</a></li><li><a href="https://www.nice.org.uk/get-involved">Get involved with NICE</a></li><li><a href="https://www.nice.org.uk/get-involved/jobs">Jobs</a></li><li><a href="https://www.nice.org.uk/news">News</a></li><li><a href="https://www.nice.org.uk/news/nice-newsletters-and-alerts">Newsletters and alerts</a></li><li><a href="https://www.nice.org.uk/get-involved/contact-us">Contact us</a></li><li><a href="https://www.nice.org.uk/leave-feedback">Leave feedback</a></li><li><a href="https://www.nice.org.uk/re-using-our-content">Reusing our content</a></li><li><a href="https://www.nice.org.uk/re-using-our-content/uk-open-content-licence">NICE UK Open Content Licence</a></li><li><a href="https://www.nice.org.uk/about/what-we-do/nice-syndication-api">Syndicate our content</a></li></ul></nav><div class="Social-module--wrapper--2nKsd"><ul class="Social-module--list--E5R5J" aria-label="NICE on social media"><li><a href="https://en-gb.facebook.com/NationalInstituteforHealthandCareExcellence/">Facebook</a></li><li><a href="https://twitter.com/NICEcomms">Twitter</a></li><li><a href="https://www.youtube.com/user/NICEmedia">YouTube</a></li><li><a href="https://www.instagram.com/nicecomms/">Instagram</a></li><li><a href="https://www.linkedin.com/company/national-institute-for-health-and-clinical-excellence">LinkedIn</a></li></ul></div></div><div class="Legal-module--wrapper--3AYMO"><div class="Legal-module--container--3TTBh"><nav class="Legal-module--menu--1e1Iy" aria-label="Legal menu"><ul><li><a href="https://www.nice.org.uk/accessibility">Accessibility</a></li><li><a href="https://www.nice.org.uk/freedom-of-information">Freedom of information</a></li><li><a href="https://www.nice.org.uk/glossary">Glossary</a></li><li><a href="https://www.nice.org.uk/terms-and-conditions">Terms and conditions</a></li><li><a href="https://www.nice.org.uk/privacy-notice">Privacy notice</a></li><li><a href="https://www.nice.org.uk/cookies">Cookies</a></li></ul></nav><p class="Legal-module--copyright--34nsI">©<!-- --> <abbr title="National Institute for Health and Care Excellence">NICE</abbr> <!-- -->2021<!-- -->. All rights reserved. Subject to<!-- --> <a href="https://www.nice.org.uk/terms-and-conditions#notice-of-rights">Notice of rights</a>.</p></div></div></footer></div><div id="gatsby-announcer" style="position:absolute;top:0;width:1px;height:1px;padding:0;overflow:hidden;clip:rect(0, 0, 0, 0);white-space:nowrap;border:0" aria-live="assertive" aria-atomic="true"></div></div><script id="gatsby-script-loader">/*<![CDATA[*/window.pagePath="/topics/vitamin-d-deficiency-in-children/management/management-of-vitamin-d-deficiency-or-insufficiency/";/*]]>*/</script><script id="gatsby-chunk-mapping">/*<![CDATA[*/window.___chunkMapping={"polyfill":["/polyfill-2cb897c2a056d28c9332.js"],"app":["/app-53a71c38b210970893c4.js"],"component---cache-caches-gatsby-plugin-offline-app-shell-js":["/component---cache-caches-gatsby-plugin-offline-app-shell-js-258fa972005c75a2a109.js"],"component---src-pages-404-tsx":["/component---src-pages-404-tsx.4b20f8dadfa146d0f95d.css","/component---src-pages-404-tsx-db046304e34e9a4e982b.js"],"component---src-pages-about-development-tsx":["/component---src-pages-about-development-tsx.4c5b5dd941fb0f6fd929.css","/component---src-pages-about-development-tsx-a805dcaba6372bd3fd34.js"],"component---src-pages-about-index-tsx":["/component---src-pages-about-index-tsx.a9a4b7f951b698486005.css","/component---src-pages-about-index-tsx-d5e998d3f688352286e1.js"],"component---src-pages-index-tsx":["/component---src-pages-index-tsx.49dafffcf9ae0c5f0d9f.css","/component---src-pages-index-tsx-6cc2ff789de11ec327f6.js"],"component---src-pages-search-tsx":["/component---src-pages-search-tsx.f915457cd8b05c27e895.css","/component---src-pages-search-tsx-a51f99760cb0d47808e2.js"],"component---src-pages-specialities-tsx":["/component---src-pages-specialities-tsx.fc62cf637c7ba1e609e7.css","/component---src-pages-specialities-tsx-90b8d3e5a5a3bff52a17.js"],"component---src-pages-topics-tsx":["/component---src-pages-topics-tsx.dfa0c1027e3cbeb11bdc.css","/component---src-pages-topics-tsx-960f75c13acbee11c017.js"],"component---src-pages-whats-new-tsx":["/component---src-pages-whats-new-tsx.7f7660f22ce5e07ac85a.css","/component---src-pages-whats-new-tsx-f78b713a66b42005fd9f.js"],"component---src-templates-chapter-level-1-chapter-level-1-tsx":["/component---src-templates-chapter-level-1-chapter-level-1-tsx.1a16ce552cccd7e50c41.css","/component---src-templates-chapter-level-1-chapter-level-1-tsx-0a03778bb80ba711929e.js"],"component---src-templates-chapter-level-2-chapter-level-2-tsx":["/component---src-templates-chapter-level-2-chapter-level-2-tsx.d09ef71dfbb262c31a03.css","/component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js"],"component---src-templates-speciality-speciality-tsx":["/component---src-templates-speciality-speciality-tsx.fc62cf637c7ba1e609e7.css","/component---src-templates-speciality-speciality-tsx-3357943d471e489a1b5f.js"],"component---src-templates-topic-topic-tsx":["/component---src-templates-topic-topic-tsx.afc04214919e241c3c2e.css","/component---src-templates-topic-topic-tsx-f17fe03d0b9a54a96aea.js"]};/*]]>*/</script><script src="../../../../polyfill-2cb897c2a056d28c9332.js" nomodule=""></script><script src="../../../../component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js" async=""></script><script src="../../../../0ad1f03a47300760909b2ab244b34289611800a7-fa70b32ffeeba2673019.js" async=""></script><script src="../../../../b95b9d9ffa67e6928854e772968693a58a7317d7-a9e1e5c953d4eee49b87.js" async=""></script><script src="../../../../app-53a71c38b210970893c4.js" async=""></script><script src="../../../../framework-34da02e39e1f104d9937.js" async=""></script><script src="../../../../webpack-runtime-28c424ef71f39faedaf0.js" async=""></script></body></html>